Document:

Employment Agreement

 Exhibit 10.1 
 EMPLOYMENT AGREEMENT 
 This Employment Agreement (“Agreement”) is made and entered into
effective as of February 11, 2008 (“Effective Date”), by and between Kenneth E. Wolf (“Employee”), and Natural Alternatives International, Inc., a Delaware corporation (“Company”). The Company and Employee may be
referred to herein collectively as the “Parties.” 
 RECITALS 
 WHEREAS, the Company wishes to retain the services of Employee as Chief Financial Officer of the Company, but only on the terms and subject to the
conditions set forth in this Agreement; and 
 WHEREAS, Employee desires to enter into the employ of the Company and is willing to do so on
the terms and conditions set forth in this Agreement. 
 NOW, THEREFORE, in consideration of the mutual promises and covenants set forth
herein and intending to be legally bound thereby, the Parties agree as follows: 
 AGREEMENT 
 1. Employment. Employee hereby accepts the offer of the Company for employment as Chief Financial Officer of the Company beginning on the
Effective Date. Employee’s employment will be at-will and may be terminated by either Employee or the Company at any time for any reason or no reason, with or without Cause (as hereinafter defined), upon written notice to the other, or without
any notice upon the death of Employee. The at-will status of the employment relationship may not be modified except by an agreement in writing signed by the President or Chief Executive Officer of the Company and Employee, the terms of which were
approved in advance in writing by the Company’s Board of Directors (which shall include any committee or subcommittee thereof authorized to determine matters of executive employment and compensation). 
 2. Employee Handbook. Employee and the Company understand and agree that nothing in the Company’s Employee Handbook is intended to be,
and nothing in it should be construed to be, a limitation of the Company’s right to terminate, transfer, demote, suspend and administer discipline at any time for any reason. Employee and the Company understand and agree nothing in the
Company’s Employee Handbook is intended to, and nothing in such Employee Handbook should be construed to, create an implied or express contract of employment contrary to this Agreement nor to relieve either party of any of its obligations under
this Agreement. 
 3. Position and Responsibilities. 
 a. During Employee’s employment with the Company hereunder, Employee shall report to the Company’s President and Board of Directors and shall
have such responsibilities, duties and authority as the Company, through its Board of Directors, may from time to time assign to Employee. Employee shall perform any other duties reasonably required by the Company and, if requested by the Company,
shall serve as a director and/or as an additional officer of the Company or any subsidiary or affiliate of the Company without additional compensation. 
  

 1 

 b. Employee, in Employee’s capacity as Chief Financial Officer of the Company, shall diligently and
to the best of Employee’s ability perform all duties that such position entails. Employee shall devote such time, energy, skill and effort to the performance of Employee’s duties hereunder as may be fairly and reasonably necessary to
faithfully and diligently further the business and interests of the Company and its subsidiaries. Employee agrees not to engage in any other business activity that would materially interfere with the performance of Employee’s duties under this
Agreement. Employee represents to the Company that Employee has no other outstanding commitments inconsistent with any of the terms of this Agreement or the services to be rendered under it. 
 c. Employee shall render Employee’s service at the Company’s offices in the County of San Diego, California, or such other location as is
mutually agreed upon by the Company and Employee. It is understood, however, and agreed that Employee’s duties may from time to time require travel to other locations, including other offices of the Company and/or its subsidiaries both within
and outside the United States. 
 4. Compensation. 
 a. Salary. During the term of Employee’s employment hereunder, the Company agrees to pay Employee a base salary of $237,500 per year, payable
in arrears no less frequently than bi-weekly in accordance with the Company’s general payroll practices. In the first year of employment, the base salary will be prorated from the start date of Employee’s employment with the Company. The
amount of Employee’s base salary as set forth in this Section 4(a) may be adjusted from time to time by an agreement in writing signed by the President or Chief Executive Officer of the Company and Employee, the terms of which were
approved in advance by action of the Company’s Board of Directors (or authorized committee or subcommittee thereof). All references in this Agreement to Employee’s base salary shall mean the base salary as adjusted from time to time.

 b. Additional Benefits. During Employee’s employment with the Company, in addition to the other compensation and benefits set
forth herein, Employee shall be entitled to receive and/or participate in such other benefits of employment generally available to the Company’s other corporate officers when and as Employee becomes eligible for them, including, without
limitation, participation in the Company’s Management Cash Incentive Plan for fiscal 2008. Employee’s participation in the Company’s Management Cash Incentive Plan for fiscal 2008 shall be at seventy five percent (75%) of the
amount in which Employee otherwise would have been entitled to participate if Employee had participated in such plan for a full fiscal year. The Company reserves the right to modify, suspend or discontinue any and all benefit plans, policies and
practices at any time without notice to or recourse by the Employee. Employee’s eligibility to participate in the Company’s Management Cash Incentive Plan in fiscal years after 2008 shall be in the sole discretion of the Company’s
Board of Directors. 
 c. No Other Compensation. Employee acknowledges and agrees that, except as expressly provided herein, and as
set forth in the Company’s Employee Handbook or any other written compensation arrangement approved by the Company’s Board of Directors, Employee is not entitled to any other compensation or benefits from the Company. 
  

 2 

 d. Withholdings. All compensation under this Agreement shall be paid less withholdings required by
federal and state law and less deductions agreed to by the Company and Employee. 
 5. Termination. 
 a. Due to Death. Employee’s employment with the Company shall terminate automatically in the event of Employee’s death. The Company shall
have no obligation to Employee or Employee’s estate for base salary or any other form of compensation or benefit other than amounts accrued through the date of Employee’s death, except as otherwise required by law or pursuant to a specific
written policy, agreement or benefit plan of the Company. 
 b. Without Cause, Severance Benefit. In the event Employee is terminated
by the Company without Cause and not as a result of death, upon Employee’s delivery to the Company of an executed general release in a form substantially similar to that set forth in Attachment #3 attached hereto (“Release”), Employee
shall be entitled to receive (i) a severance benefit, including standard employee benefits available to the Company’s other corporate officers, in an amount equal to three (3) months’ base salary; and (ii) continuing group
health insurance coverage pursuant to COBRA for the three (3) months following termination with the premiums for such continuation coverage paid by the Company. If Employee does not execute and deliver the Release, Employee shall only be
entitled to receive a severance benefit in an amount equal to four (4) weeks’ base salary and the Company shall not pay any premiums for continuing group health insurance coverage pursuant to COBRA or otherwise. One half of any severance
benefit owing hereunder shall be paid within ten (10) business days of termination and the balance shall be paid on a bi-weekly basis over the applicable severance period of four (4) weeks or three (3) months. 
 c. With Cause, No Severance Benefit. The Company may terminate Employee for Cause. For purposes of this Agreement, “Cause” shall mean
the occurrence of one or more of the following events: (i) the Employee’s commission of any fraud against the Company or any of its subsidiaries; (ii) Employee’s intentional appropriation for Employee’s personal use or
benefit of the funds of the Company or of its subsidiaries not authorized in writing by the Board of Directors; (iii) Employee’s conviction of any crime involving moral turpitude; (iv) Employee’s conviction of a violation of any
state or federal law that could result in a material adverse impact upon the business of the Company or its subsidiaries; (v) Employee engaging in any other professional employment or consulting or directly or indirectly participating in or
assisting any business that is a current or potential supplier, customer or competitor of the Company or its subsidiaries without prior written approval from the Company’s Board of Directors; (vi) Employee’s failure to comply with the
Company’s written policy on acceptance of gifts and gratuities as in effect from time to time; or (vii) when Employee has been disabled and is unable to perform the essential functions of the position for any reason notwithstanding
reasonable accommodation, provided Employee has received from the Company compensation in an amount equivalent to Employee’s severance benefit payment. No severance benefit shall be due to Employee if Employee is terminated for Cause, including
if Employee is terminated for Cause upon or after a Change in Control (as hereinafter defined and separately addressed below), except in the event of disability as set forth above. 
 d. Resignation or Retirement, No Severance Benefit. This Agreement shall be terminated upon Employee’s voluntary retirement or resignation.
No severance benefit shall be due to Employee if Employee resigns or retires from employment for any reason or at any time, including upon or after a Change in Control. 
  

 3 

 e. Payment Through Date of Termination. Except as otherwise set forth herein, upon the termination
of this Agreement for any reason, Employee shall be entitled to receive any unpaid compensation earned through the effective date of termination. If this Agreement is terminated for any reason before year-end bonus or other compensation becoming
payable to Employee, then such bonus and other compensation shall be forfeited in full by Employee. 
 6. Termination
Obligations. 
 a. Return of Company Property. Upon termination of this Agreement and cessation of Employee’s employment,
Employee agrees to return all Company Property (as such term is defined in Attachment #2 to this Agreement) to the Company promptly, but in no event later than two (2) business days following termination of employment. 
 b. Termination of Benefits. Any and all benefits to which Employee is otherwise entitled shall cease upon Employee’s termination, unless
explicitly continued either under this Agreement or under any specific written policy or benefit plan of the Company. 
 c. Termination of
Other Positions. Upon termination of Employee’s employment with the Company, Employee shall be deemed to have resigned from all other offices and directorships then held with the Company or its subsidiaries, unless otherwise expressly
agreed in a writing signed by the Parties. 
 d. Employee Cooperation. Following termination of Employee’s employment, Employee
shall cooperate fully with the Company in all matters including, but not limited to, advising the Company of all pending work on behalf of the Company and the orderly transfer of work to other employees or representatives of the Company. Employee
shall also cooperate in the defense of any action brought by any third party against the Company that relates in any way to Employee’s acts or omissions while employed by the Company. 
 e. Survival of Obligations. Employee’s obligations under this Section 6 shall survive the termination of employment and the termination
of this Agreement. 
 7. Change in Control. In the event of any Change in Control, the following provisions will apply.

 a. Any of the following shall constitute a “Change in Control” for the purposes of this Agreement: 
 (i) The consummation of a merger or consolidation of the Company with or into another entity or any other corporate reorganization, if more than 50% of
the combined voting power of the continuing or surviving entity’s securities outstanding immediately after such merger, consolidation or other reorganization is owned by persons who were not stockholders of the Company immediately prior to such
merger, consolidation or other reorganization; 
  

 4 

 (ii) The sale, transfer or other disposition of all or substantially all of the Company’s assets;

 (iii) A change in the composition of the Company’s Board of Directors, as a result of which fewer than 50% of the incumbent
directors are directors who either (i) had been directors of the Company on the date 24 months prior to the date of the event that may constitute a Change in Control (the “original directors”) or (ii) were elected, or nominated
for election, to the Board of Directors with the affirmative votes of at least a majority of the aggregate of the original directors who were still in office at the time of the election or nomination and the directors whose election or nomination
was previously so approved; or 
 (iv) Any transaction as a result of which any person is the “beneficial owner” (as defined in
Rule 13d-3 under the Securities Exchange Act of 1934, as amended (“Exchange Act”)), directly or indirectly, of securities of the Company representing at least 20% of the total voting power represented by the Company’s then outstanding
voting securities. For this purpose, the term “person” shall have the same meaning as when used in Sections 13(d) and 14(d) of the Exchange Act but shall exclude (i) a trustee or other fiduciary holding securities under an employee
benefit plan of the Company or of a parent or subsidiary of the Company and (ii) a corporation owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the common stock of the
Company. 
 A transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Company’s
incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction. 
 b. In the event of a Change in Control, this Agreement shall continue in effect unless terminated by Employee or the Company. 
 c. If Employee is terminated without Cause following a Change in Control by the Company and/or the surviving or resulting corporation, upon
Employee’s delivery to the Company of an executed Release, Employee shall be entitled to receive as severance pay or liquidated damages, or both, (i) a lump sum payment (“Change in Control Severance Payment”) in an amount equal
to one (1) year’s compensation or such greater amount as the Board of Directors determines from time to time pursuant to terms which may not be revoked or reduced thereafter; and (ii) continuing group health insurance coverage
pursuant to COBRA for the twelve (12) months following termination with the premiums for such continuation coverage paid by the Company. If Employee does not execute and deliver the Release, Employee shall only be entitled to receive a Change
in Control Severance Payment in an amount equal to four (4) weeks’ compensation and the Company shall not pay any premiums for continuing group health insurance coverage pursuant to COBRA or otherwise. 
 d. Subject to applicable law, any Change in Control Severance Payment shall be made not later than the fifteenth (15th) day following the effective
date of Employee’s termination without Cause in connection with a Change in Control; provided, however, that if the amount of such payment cannot be finally determined on or before such date, the Company shall pay to Employee on such date a
good faith estimate of the minimum amount of such payment, and, subject to applicable law, shall pay the remainder of such payment (together with interest at the rate provided in Section 1274(b)(2)(B) of the Internal Revenue Code of 1986, as
amended 

  

 5 

 
(“Code”)), as soon as the amount thereof can be determined, but in no event later than the thirtieth (30th) day after the applicable
termination date. If the amount of the estimated payment exceeds the amount subsequently determined to have been due, such excess shall constitute a loan by the Company to Employee payable on the fifteenth (15th) day after receipt by Employee
of a written demand for payment from the Company (together with interest calculated as set forth above). The total of any payment pursuant to this Section 7 shall be limited to the extent necessary, in the opinion of legal counsel acceptable to
Employee and the Company, to avoid the payment of an “excess parachute” payment within the meaning of Section 280G of the Code or any similar successor provision. 
 e. In the event of termination of Employee’s employment under Section 7(c), and provided Employee delivers to the Company an executed Release,
the Company shall cause each then-outstanding stock option granted by the Company to the Employee as of the date of termination to become fully exercisable and to remain exercisable for the term of the option. 
 8. Arbitration. Employee and the Company hereby agree to the Mutual Agreement to Mediate and Arbitrate Claims attached hereto as Attachment
#1 and made a part hereof. Employee’s obligations under this Section 8 and such Mutual Agreement to Mediate and Arbitrate Claims shall survive the termination of employment and the termination of this Agreement. 
 9. Confidential Information and Inventions. Employee and the Company hereby agree to the Confidential Information and Invention Assignment
Agreement, Covenant of Exclusivity and Covenant Not to Compete attached hereto as Attachment #2 and made a part hereof. Employee’s obligations under this Section 9 and such Confidential Information and Invention Assignment Agreement,
Covenant of Exclusivity and Covenant Not to Compete shall survive the termination of employment and the termination of this Agreement. 
 10.
Competitive Activity. Employee covenants, warrants and represents that during the period of Employee’s employment with the Company, Employee shall not engage anywhere, directly or indirectly (as a principal, shareholder, partner,
director, manager, member, officer, agent, employee, consultant or otherwise), or be financially interested in any business that is involved in business activities that are the same as, similar to, or in competition with the business activities
carried on by the Company or any business that is a current or potential supplier, customer or competitor of the Company without prior written approval from the Company’s Board of Directors. Notwithstanding the foregoing, Employee may invest in
and hold up to one percent (1%) of the outstanding voting stock of a publicly held company that is involved in business activities that are the same as, similar to, or in competition with the business activities carried on by the Company or any
business that is a current or potential supplier, customer or competitor of the Company without the prior written approval of the Company’s Board of Directors; provided, however, that if such publicly held company is a current or potential
supplier, customer or competitor of the Company, the Employee shall advise the Audit Committee of the Company’s Board of Directors in writing of Employee’s investment in such company as soon as reasonably practicable. 
 11. Employee Conduct. Employee covenants, warrants and represents that during the period of Employee’s employment with the Company,
Employee shall at all times comply with the Company’s written policy as in effect from time to time on the acceptance of gifts and gratuities from customers, vendors, suppliers, or other persons doing business with the Company. 

  

 6 

 
Employee represents and understands that acceptance or encouragement of any gift or gratuity not in compliance with such policy may create a perceived
financial obligation and/or conflict of interest for the Company and shall not be permitted as a means to influence business decisions, transactions or service. In this situation, as in all other areas of employment, Employee is expected to conduct
himself or herself using the highest ethical standard. 
 12. Miscellaneous Provisions. 
 a. Entire Agreement. This Agreement and any attachments and/or exhibits contains the entire agreement between the Parties. It supersedes any and
all other agreements, either oral or in writing, between the Parties with respect to Employee’s employment by the Company. Each party to this Agreement acknowledges that no representations, inducements, promises or agreements, oral or
otherwise, have been made by any party, or anyone acting on behalf of any party, which are not embodied herein and acknowledges that no other agreement, statement or promise not contained in this Agreement shall be valid or binding. To the extent
the practices, policies or procedures of the Company, now or in the future, are inconsistent with the terms of this Agreement, the provisions of this Agreement shall control. 
 b. Governing Law. This Agreement shall be construed and enforced in accordance with the laws of the State of California. 
 c. Severability. Should any part or provision of this Agreement be held by a court of competent jurisdiction to be illegal, unenforceable, invalid
or void, the remaining provisions of this Agreement shall continue in full force and effect and the validity of the remaining provisions shall not be affected by such holding. 
 d. Attorneys’ Fees. Except as set forth in the Mutual Agreement to Mediate and Arbitrate Claims attached hereto as Attachment #1, should any
party institute any action, arbitration or proceeding to enforce, interpret or apply any provision of this Agreement, the Parties agree that the prevailing party shall be entitled to reimbursement by the non-prevailing party of all recoverable costs
and expenses, including, but not limited to, reasonable attorneys’ fees. 
 e. Interpretation. This Agreement shall be construed
as a whole, according to its fair meaning, and not in favor of or against any party. By way of example and not in limitation, this Agreement shall not be construed in favor of the party receiving a benefit nor against the party responsible for any
particular language in this Agreement. The headings and captions contained in this Agreement are for convenience of reference only and shall not constitute a part of this Agreement and shall not be used in the construction or interpretation of this
Agreement. 
 f. Amendment; Waiver. This Agreement may not be modified or amended by oral agreement or course of conduct, but only by
an agreement in writing signed by the President or Chief Executive Officer of the Company and Employee, the terms of which were approved in advance in writing by the Company’s Board of Directors. The failure of either party hereto at any time
to require the performance by the other party hereto of any provision hereof shall in no way affect the full right to require such performance at any time thereafter, nor shall the waiver by either party hereto of a breach of any provision hereof be
taken or held to be a waiver of any succeeding breach of such provision or waiver of the provision itself or a waiver of any other provision of this Agreement. 
  

 7 

 g. Assignment. This Agreement is binding on and is for the benefit of the Parties and their
respective successors, heirs, executors, administrators and other legal representatives. Neither this Agreement nor any right or obligation hereunder may be assigned by the Company (except to an affiliate of the Company or to a person, as defined
herein, in accordance with a Change in Control) or by the Employee. 
 h. No Restrictions; No Violation. The Employee represents and
warrants that: (i) Employee is not a party to any agreement that would restrict or prohibit Employee from entering into this Agreement or performing fully Employee’s obligations hereunder; and (ii) the execution by Employee of this
Agreement and the performance by Employee of Employee’s obligations and duties pursuant to this Agreement will not result in any breach of any other agreement to which Employee is a party. 
 i. Counterparts. This Agreement may be executed in counterparts, each of which will be deemed an original copy of this Agreement and all of which,
when taken together, will be deemed to constitute one and the same agreement. The exchange of copies of this Agreement and of signature pages by facsimile transmission shall constitute effective execution and delivery of this Agreement as to the
Parties and may be used in lieu of the original Agreement for all purposes. Signatures of the parties transmitted by facsimile shall be deemed to be their original signatures for all purposes. 
 j. Legal Representation; Independent Counsel. The law firm of Bell Boyd & Lloyd LLP has prepared this Agreement on behalf of the
Company based on the Company’s instructions. Bell Boyd & Lloyd LLP does not represent any other party to this Agreement. In executing this Agreement, Employee represents that Employee has neither requested nor been given legal advice
or counsel by Bell Boyd & Lloyd LLP or any of its attorneys. Employee is aware of Employee’s right to obtain separate legal counsel with respect to the negotiation and execution of this Agreement and acknowledges that Bell
Boyd & Lloyd LLP has recommended that Employee retain Employee’s own counsel for such purpose. Employee further acknowledges that Employee (i) has read and understands this Agreement and its exhibits and attachments; (ii) has
had the opportunity to retain separate counsel in connection with the negotiation and execution of this Agreement; and (iii) has relied on the advice of separate counsel with respect to this Agreement or made the conscious decision not to
retain counsel in connection with the negotiation and execution of this Agreement. 
 [Signatures on following page.] 
  

 8 

 IN WITNESS WHEREOF, the Parties have executed this Agreement effective as of the Effective Date.

  

			
	 EMPLOYEE

	
	 /s/ Kenneth Wolf

	 Kenneth Wolf

	
	 COMPANY

	
	 Natural Alternatives International, Inc.,
 a
Delaware corporation

		
	 By:
	 	 /s/ Randell Weaver

		 	Randell Weaver, President

  

 9 

 ATTACHMENT #1 
 MUTUAL AGREEMENT TO MEDIATE AND ARBITRATE CLAIMS 
 This Mutual Agreement to Mediate and Arbitrate
Claims (“Agreement”) is made and entered into effective as of February 11, 2008 (“Effective Date”), by and between Kenneth E. Wolf (“Employee”), and Natural Alternatives International, Inc., a Delaware corporation
(“Company”). 
 In consideration of and as a condition of Employee’s prospective and continued employment relationship with
the Company, Employee’s employment rights under Employee’s Employment Agreement, Employee’s participation in the Company’s benefit programs (when and if eligible), Employee’s access to and receipt of confidential information
of the Company, and other good and valuable consideration, all of which Employee considers to have been negotiated at arm’s length, Employee and Company agree to the following: 
 1. Claims Covered by this Agreement. 
 a. To the fullest extent permitted by law, all claims and disputes between Employee (and Employee’s successors and assigns) and the Company relating in any manner whatsoever to the employment or termination of Employee, including
without limitation all claims and disputes arising under this Agreement or that certain Employment Agreement entered into by and between the Company and Employee on equal date hereof, as may be amended from time to time (“Employment
Agreement”), shall be resolved by mediation and arbitration as set forth herein. All persons and entities specified in the preceding sentence (other than the Company and Employee) shall be considered third-party beneficiaries of the rights and
obligations created by this Agreement. Claims and disputes covered by this Agreement include without limitation those arising under: 
 (i)
Any federal, state or local laws, regulations or statutes prohibiting employment discrimination (including, without limitation, discrimination relating to race, sex, national origin, age, disability, religion, or sexual orientation) and harassment;

 (ii) Any alleged or actual agreement or covenant (oral, written or implied) between Employee and the Company; 
 (iii) Any Company policy, compensation, wage or related claim or benefit plan, unless the decision in question was made by an entity other than the
Company; 
 (iv) Any public policy; and 
 (v) Any other claim for personal, emotional, physical or economic injury. 
 b. The only disputes between
Employee and the Company that are not included within this Agreement are: 
 (i) Any claim by Employee for workers’ compensation or
unemployment compensation benefits; and 
  

 1 

 (ii) Any claim by Employee for benefits under a Company plan that provides for its own arbitration
procedure. 
 2. Mandatory Mediation of Claims and Disputes. 
 a. If any claim or dispute covered under this Agreement cannot be resolved by negotiation between the parties, the following mediation and arbitration
procedures shall be invoked. Before invoking the binding arbitration procedure set forth below, the Company and Employee shall first participate in mandatory mediation of any dispute or claim covered under this Agreement. 
 b. The claim or dispute shall be submitted to mediation before a mediator of the Judicial Arbitration and Mediation Service (“JAMS”), a
mutually agreed to alternative dispute resolution (“ADR”) organization. The mediation shall be conducted at a mutually agreeable location, or if a location cannot be agreed to by the parties, at a location chosen by the mediator. The
administrator of the ADR organization shall select three (3) mediators. From the three (3) chosen, each party shall strike one and the remaining mediator shall preside over the mediation. The cost of the mediation shall be borne by the
Company. 
 c. At least ten (10) business days before the date of the mediation, each side shall provide the mediator with a statement
of its position and copies of all supporting documents. Each party shall send to the mediation a person who has authority to bind the party. If a subsequent dispute will involve third parties, such as insurers, they shall also be asked to
participate in the mediation. 
 d. If a party has participated in the mediation and is dissatisfied with the outcome, that party may invoke
the arbitration procedure set forth below. 
 3. Binding Arbitration of Claims and Disputes. 
 a. If the Company and Employee are unable to resolve a dispute or claim covered under this Agreement through mediation, they shall submit any such dispute
or claim to binding arbitration, in accordance with California Code of Civil Procedure §§1280 through 1294.2. Either party may enforce the award of the arbitrator under Code of Civil Procedure §1285 by any competent court of law.
Employee and the Company understand that they are, to the greatest extent permitted under California law, waiving their rights to a jury trial. 
 b. The party demanding arbitration shall submit a written claim to the other party, setting out the basis of the claim and proposing the name of an arbitrator from JAMS, the mutually agreed to ADR organization. The responding party shall
have ten (10) business days in which to respond to this demand in a written answer. If this response is not timely made, or if the responding party agrees with the person proposed as the arbitrator, then the person named by the demanding party
shall serve as the arbitrator. If the responding party submits a written answer rejecting the proposed arbitrator then, on the request of either party, JAMS shall appoint an arbitrator other than the mediator. The Employee and the Company agree to
apply American Arbitration Association (“AAA”) rules for the resolution of employment disputes to the arbitration even though the ADR is one other than AAA. No one who has ever had any business, financial, family, or social relationship
with any party to this Agreement shall serve as an arbitrator unless the related party informs the other party of the relationship and the other party consents in writing to the use of that arbitrator. 
  

 2 

 c. The arbitration shall take place in the county of San Diego, California, at a time and place selected
by the arbitrator. A pre-arbitration hearing shall be held within ten (10) business days after the arbitrator’s selection. The arbitration shall be held within sixty (60) calendar days after the pre-arbitration hearing. The arbitrator
shall establish all discovery and other deadlines necessary to accomplish this goal. 
 d. Each party shall be entitled to discovery of
essential documents and witnesses, as determined by the arbitrator in accordance with the then-applicable rules of discovery for the resolution of employment disputes and the time frame set forth in this Agreement. The arbitrator may resolve any
disputes over any discovery matters as they would be resolved in civil litigation. 
 e. The arbitrator shall have the following powers:

 (i) to issue subpoenas for the attendance of witnesses and subpoenas duces tecum for the production of books, records, documents, and
other evidence; 
 (ii) to order depositions to be used as evidence; 
 (iii) subject to the limitations on discovery enumerated above, to enforce the rights, remedies, procedures, duties, liabilities, and obligations of
discovery as if the arbitration were a civil action before a California superior court; 
 (iv) to conduct a hearing on the arbitrable
issues; and 
 (v) to administer oaths to parties and witnesses. 
 f. Within fifteen (15 days) after completion of the arbitration, the arbitrator shall submit a tentative decision in writing, specifying the reasoning
for the decision and any calculations necessary to explain the award. Each party shall have fifteen (15) days in which to submit written comments to the tentative decision. Within ten (10) days after the deadline for written comments, the
arbitrator shall announce the final award. 
 g. The Company shall pay the arbitrator’s expenses and fees, all meeting room charges, and
any other expenses that would not have been incurred if the case were litigated in the judicial forum having jurisdiction over it. Unless otherwise ordered by the arbitrator, each party shall pay its own attorneys’ fees and witness fees, and
other expenses incurred by the party for such party’s own benefit and not required to be paid by the Company pursuant to the terms hereof. Regardless of any statute, procedure, rule or law, the prevailing party in arbitration shall be entitled
to recover from the non-prevailing party reasonable attorneys’ fees incurred as a result of arbitration. 
  

 3 

 4. Miscellaneous Provisions. 
 a. For purposes hereof, the term “Company” shall also include all related entities, affiliates and subsidiaries, all officers, employees,
directors, agents, stockholders, partners, managers, members, benefit plan sponsors, fiduciaries, administrators or affiliates of any of the above, and all successors and assigns of any of the above. 
 b. If either party pursues a covered claim against the other by any action, method or legal proceeding other than mediation or arbitration as provided
herein, the responding party shall be entitled to dismissal or injunctive relief regarding such action and recovery of all costs, losses and attorneys’ fees related to such other action or proceeding. 
 c. This is the complete agreement of the parties on the subject of mediation and the arbitration of disputes and claims covered hereunder. This Agreement
supersedes any prior or contemporaneous oral, written or implied understanding on the subject, shall survive the termination of Employee’s employment and can only be revoked or modified by a written agreement signed by Employee and the
President or Chief Executive Officer of the Company, the terms of which were approved in advance in writing by the Company’s Board of Directors and which specifically state an intent to revoke or modify this Agreement. If any provision of this
Agreement is adjudicated to be void or otherwise unenforceable in whole or in part, such adjudication shall not affect the validity of the remainder of the Agreement, which shall remain in full force and effect. 
 d. This Agreement shall be construed and enforced in accordance with the laws of the State of California. 
 e. This Agreement shall be construed as a whole, according to its fair meaning, and not in favor of or against any party. By way of example and not in
limitation, this Agreement shall not be construed in favor of the party receiving a benefit nor against the party responsible for any particular language in this Agreement. The headings and captions contained in this Agreement are for convenience of
reference only and shall not constitute a part of this Agreement and shall not be used in the construction or interpretation of this Agreement. 
 f. The failure of either party hereto at any time to require the performance by the other party hereto of any provision hereof shall in no way affect the full right to require such performance at any time thereafter, nor shall the waiver by
either party hereto of a breach of any provision hereof be taken or held to be a waiver of any succeeding breach of such provision or waiver of the provision itself or a waiver of any other provision of this Agreement. 
 g. This Agreement may be executed in counterparts, each of which will be deemed an original copy of this Agreement and all of which, when taken together,
will be deemed to constitute one and the same agreement. The exchange of copies of this Agreement and of signature pages by facsimile transmission shall constitute effective execution and delivery of this Agreement as to the parties and may be used
in lieu of the original Agreement for all purposes. Signatures of the parties transmitted by facsimile shall be deemed to be their original signatures for all purposes. 
 h. Employee’s and Company’s obligations under this Agreement shall survive the termination of Employee’s employment and the termination of the Employment Agreement. 
  

 4 

 i. The law firm of Bell, Boyd & Lloyd LLP has prepared this Agreement on behalf of the Company
based on the Company’s instructions. Bell, Boyd & Lloyd LLP does not represent any other party to this Agreement. In executing this Agreement, Employee represents that Employee has neither requested nor been given legal advice or
counsel by Bell, Boyd & Lloyd LLP or any of its attorneys. Employee is aware of Employee’s right to obtain separate legal counsel with respect to the negotiation and execution of this Agreement and acknowledges that Bell,
Boyd & Lloyd LLP has recommended that Employee retain Employee’s own counsel for such purpose. Employee further acknowledges that Employee (i) has read and understands this Agreement; (ii) has had the opportunity to retain
separate counsel in connection with the negotiation and execution of this Agreement; and (iii) has relied on the advice of separate counsel with respect to this Agreement or made the conscious decision not to retain counsel in connection with
the negotiation and execution of this Agreement. 
 IN WITNESS WHEREOF, the parties have executed this Agreement as of the Effective Date.

  

			
	EMPLOYEE
	
	 /s/ Kenneth E. Wolf

	Kenneth E. Wolf
	
	COMPANY
	
	 Natural Alternatives International, Inc.,
 a
Delaware corporation

		
	By:	 	 /s/ Randell Weaver

		 	Randell Weaver, President

  

 5 

 ATTACHMENT #2 
 CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENT, 
 COVENANT OF EXCLUSIVITY AND COVENANT
NOT TO COMPETE 
 This Confidential Information and Invention Assignment Agreement, Covenant of Exclusivity and Covenant Not to Compete
(“Agreement”) is made by Kenneth E. Wolf (“Employee” or “I,” “me” or “my”), and accepted and agreed to by Natural Alternatives International, Inc., a Delaware corporation (“Company”), as of
February 11, 2008 (“Effective Date”). 
 In consideration of and as a condition of my prospective and continued employment
relationship with the Company (which for purposes of this Agreement shall be deemed to include any subsidiaries or affiliates of the Company, where “affiliate” shall mean any person or entity that directly or indirectly controls, is
controlled by, or is under common control with the Company), my employment rights under my Employment Agreement with the Company effective as of the Effective Date, as well as my access to and receipt of confidential information of the Company, and
other good and valuable consideration, I agree to the following, and I agree the following shall be in addition to the terms and conditions of any Confidential Information and Invention Assignment Agreement executed by employees of the Company
generally, and which I may execute in addition hereto: 
 1. Inventions. 
 a. Disclosure. I will disclose promptly in writing to the appropriate officer or other representative of the Company, any idea, invention, work of
authorship, design, formula, pattern, compilation, program, device, method, technique, process, improvement, development or discovery, whether or not patentable or copyrightable or entitled to legal protection as a trade secret, trademark service
mark, trade name or otherwise (“Invention”), that I may conceive, make, develop, reduce to practice or work on, in whole or in part, solely or jointly with others (“Invent”), during the period of my employment with the Company.

 i. The disclosure required by this Section 1(a) applies to each and every Invention that I Invent (1) whether during my regular
hours of employment or during my time away from work, (2) whether or not the Invention was made at the suggestion of the Company, and (3) whether or not the Invention was reduced to or embodied in writing, electronic media or tangible
form. 
 ii. The disclosure required by this Section 1(a) also applies to any Invention which may relate at the time of conception or
reduction to practice of the Invention to the Company’s business or actual or demonstrably anticipated research or development of the Company, and to any Invention which results from any work performed by me for the Company. 
 iii. The disclosure required by this Section 1(a) shall be received in confidence by the Company within the meaning of and to the extent required
by California Labor Code §2871, the provisions of which are set forth on Exhibit A attached hereto. 
 iv. To facilitate the complete
and accurate disclosures described above, I shall maintain complete written records of all Inventions and all work, study and investigation done by me during my employment, which records shall be the Company’s property. 
  

 1 

 v. I agree that during my employment I shall have a continuing obligation to supplement the disclosure
required by this Section 1(a) on a monthly basis if I Invent an Invention during the period of employment. In order to facilitate the same, the Company and I shall periodically review every six months the written records of all Inventions as
outlined in this Section 1(a) to determine whether any particular Invention is in fact related to Company business. 
 b.
Assignment. I hereby assign to the Company without royalty or any other further consideration my entire right, title and interest in and to each and every Invention I am required to disclose under Section 1(a) other than an Invention
that (i) I have or shall have developed entirely on my own time without using the Company’s equipment, supplies, facilities or trade secret information, (ii) does not relate at the time of conception or reduction to practice of the
Invention to the Company’s business, or actual or demonstrably anticipated research or development of the Company, and (iii) does not result from any work performed by me for the Company. I acknowledge that the Company has notified me that
the assignment provided for in this Section l(b) does not apply to any Invention to which the assignment may not lawfully apply under the provisions of Section §2870 of the California Labor Code, a copy of which is attached hereto as Exhibit A.
I shall bear the full burden of proving to the Company that an Invention qualifies fully under Section §2870. 
 c. Additional
Assistance and Documents. I will assist the Company in obtaining, maintaining and enforcing patents, copyrights, trade secrets, trademarks, service marks, trade names and other proprietary rights in connection with any Invention I have assigned
to the Company under Section l(b), and I further agree that my obligations under this Section l(c) shall continue beyond the termination of my employment with the Company. Among other things, for the foregoing purposes I will (i) testify at the
request of the Company in any interference, litigation or other legal proceeding that may arise during or after my employment, and (ii) execute, verify, acknowledge and deliver any proper document and, if, because of my mental or physical
incapacity or for any other reason whatsoever, the Company is unable to obtain my signature to apply for or to pursue any application for any United States or foreign patent or copyright covering Inventions assigned to the Company by me, I hereby
irrevocably designate and appoint each of the Company and its duly authorized officers and agents as my agent and attorney in fact to act for me and in my behalf and stead to execute and file any such applications and to do all other lawfully
permitted acts to further the prosecution and issuance of any United States or foreign patent or copyright thereon with the same legal force and effect as if executed by me. I shall be entitled to reimbursement of any out-of-pocket expenses incurred
by me in rendering such assistance and, if I am required to render such assistance after the termination of my employment, the Company shall pay me a reasonable rate of compensation for time spent by me in rendering such assistance to the extent
permitted by law (provided, I understand that no compensation shall be paid for my time in connection with preparing for or rendering any testimony or statement under oath in any judicial proceeding, arbitration or similar proceeding). 

d. Prior Contracts and Inventions; Rights of Third Parties. I represent to the Company that, except as set forth on Exhibit B attached hereto,
there are no other contracts to assign Inventions now in existence between me and any other person or entity (and if 

  

 2 

 
no Exhibit B is attached hereto or there is no such contract(s) described thereon, then it means that by signing this Agreement, I represent to the Company
that there is no such other contract(s)). In addition, I represent to the Company that I have no other employments or undertaking which do or would restrict or impair my performance of this Agreement. I further represent to the Company that Exhibit
C attached hereto sets forth a brief description of all Inventions made or conceived by me prior to my employment with the Company which I desire to be excluded from this Agreement (and if no Exhibit C is attached hereto or there is no such
description set forth thereon, then it means that by signing this Agreement I represent to the Company that there is no such Invention made or conceived by me prior to my employment with the Company). In connection with my employment with the
Company, I promise not to use or disclose to the Company any patent, copyright, confidential trade secret or other proprietary information of any previous employer or other person that I am not lawfully entitled so to use or disclose. If in the
course of my employment with the Company I incorporate into an Invention or any product process or service of the Company any Invention made or conceived by me prior to my employment with the Company, I hereby grant to the Company a royalty-free,
irrevocable, worldwide nonexclusive license to make, have made, use and sell that Invention without restriction as to the extent of my ownership or interest. 
 2. Confidential Information. 
 a. Company Confidential Information. I will not use or
disclose, produce, publish, permit access to, or reveal Confidential Information, whether before, during or after the period of my employment with the Company except to perform my duties as an employee of the Company based on my reasonable judgment
as an officer of the Company, or in accordance with instruction or authorization of the Company, without prior written consent of the Company or pursuant to process or requirements of law after I have disclosed such process or requirements to the
Company so as to afford the Company the opportunity to seek appropriate relief therefrom. “Confidential Information” means any Invention of any person in which the Company has an interest and in addition means all information and material
that is proprietary to the Company, whether or not marked as “confidential” or “proprietary,” and which is disclosed to or obtained by me, which relates to the Company’s past, present or future business activities.
Confidential Information includes all information or materials prepared by or for the Company and includes, without limitation, all of the following: designs, drawings, specifications, techniques, models, data, source code, object code,
documentation, diagrams, flow charts, research, development, processes, procedures, “know-how,” new product or new technology information, product copies, development or marketing techniques and materials, development or marketing
timetables, strategies and development plans, including trade names, trademarks, customer, supplier or personnel names and other information related to customers, suppliers or personnel, pricing policies and financial information, and other
information of a similar nature, whether or not reduced to writing or other tangible form, and any other trade secrets or nonpublic business information. Confidential Information is to be broadly defined, and includes all information that has or
could have commercial value or other utility in the business in which the Company is engaged or contemplates engaging, and all information of which the unauthorized disclosure could be detrimental to the interests of the Company, whether or not such
information is identified as Confidential Information by the Company. 
 b. Third Party Information. I acknowledge that during my
employment with the Company I may have access to patent, copyright, confidential, trade secret or other 

  

 3 

 
proprietary information of third parties, some of which may be subject to restrictions on the use or disclosure thereof by the Company. During the period of
my employment and thereafter, I agree not to use or disclose, produce, publish, permit access to, or reveal any such information other than consistent with the restrictions and my duties as an employee of the Company. 
 3. Property of the Company. All equipment and all tangible and intangible information relating to the Company, its employees, its customers
and its vendors and business furnished to, obtained by, or prepared by me or any other person during the course of or incident to employment by the Company are and shall remain the sole property of the Company (“Company Property”). For
purposes of this Agreement, Company Property shall include, but not be limited to, computer equipment, books, manuals, records, reports, notes, correspondence, contracts, customer lists, business cards, advertising, sales, financial, personnel,
operations, and manufacturing materials and information, data processing reports, computer programs, software, customer information and records, business records, price lists or information, and samples, and in each case shall include all copies
thereof in any medium, including paper, electronic and magnetic media and all other forms of information storage. Upon termination of my employment with the Company, I agree to return all tangible Company Property to the Company promptly, but in no
event later than two (2) business days following termination of employment. 
 4. No Solicitation of Company Employees.
While employed by the Company and for a period of one year after termination of my employment with the Company, I agree not to induce or attempt to influence directly or indirectly any employee of the Company to terminate employment with the Company
or to work for me or any other person or entity. 
 5. Covenant of Exclusivity and Not to Compete. During the period of my
employment with the Company, I will not engage in any other professional employment or consulting or directly or indirectly participate in or assist any business which is a current or potential supplier, customer or competitor of the Company without
prior written approval from the Company’s Board of Directors. 
 6. Miscellaneous Provisions. 
 a. Successors and Assignees; Assignment. All representations, warranties, covenants and agreements of the parties shall bind their respective
heirs, executors, personal representatives, successors and assignees (“transferees”) and shall inure to the benefit of their respective permitted transferees. The Company shall have the right to assign any or all of its rights and to
delegate any or all of its obligations hereunder. Employee shall not have the right to assign any rights or delegate any obligations hereunder without the prior written consent of the Company or its transferee. 
 b. Number and Gender; Headings. Each number and gender shall be deemed to include each other number and gender as the context may require. The
headings and captions contained in this Agreement shall not constitute a part thereof and shall not be used in its construction or interpretation. 
 c. Severability. If any provision of this Agreement is found by any court or arbitral tribunal of competent jurisdiction to be invalid or unenforceable, the invalidity of such provision shall not affect the other provisions of this
Agreement and all provisions not affected by the invalidity shall remain in full force and effect. 
  

 4 

 d. Amendment and Modification. This Agreement may be amended or modified only by a writing
executed by the President or Chief Executive Officer of the Company and Employee. 
 e. Government Law. The laws of California shall
govern the construction, interpretation and performance of this Agreement and all transactions under it. 
 f. Remedies. I acknowledge
that my failure to carry out any obligation under this Agreement, or a breach by me of any provision herein, will constitute immediate and irreparable damage to the Company, which cannot be fully and adequately compensated in money damages and which
will warrant preliminary and other injunctive relief, an order for specific performance, and other equitable relief. I further agree that no bond or other security shall be required in obtaining such equitable relief and I hereby consent to the
issuance of such injunction and to the ordering of specific performance. I also understand that other action may be taken and remedies enforced against me. 
 g. Mediation and Arbitration. This Agreement is subject to the Mutual Agreement to Mediate and Arbitrate Claims attached to the Employment Agreement between me and the Company, incorporated into this Agreement
by this reference. 
 h. Attorneys’ Fees. Unless otherwise set forth in the Mutual Agreement to Mediate and Arbitrate Claims
between Employee and the Company, should either I or the Company, or any heir, personal representative, successor or permitted assign of either party, resort to arbitration or legal proceedings to enforce this Agreement, the prevailing party (as
defined in California statutory law) in such proceeding shall be awarded, in addition to such other relief as may be granted, reasonable attorneys’ fees and costs incurred in connection with such proceeding. 
 i. No Effect on Other Terms or Conditions of Employment. I acknowledge that this Agreement does not affect any term or condition of my employment
except as expressly provided in this Agreement, and that this Agreement does not give rise to any right or entitlement on my part to employment or continued employment with the Company. I further acknowledge that this Agreement does not affect in
any way the right of the Company to terminate my employment. 
 j. Legal Representation; Advice of Counsel. The law firm of Bell,
Boyd & Lloyd LLP has prepared this Agreement on behalf of the Company based on its instructions. Bell, Boyd & Lloyd LLP does not represent any other party to this Agreement. In executing this Agreement, I represent that I have
neither requested nor been given legal advice or counsel by Bell, Boyd & Lloyd LLP or any of its attorneys. I am aware of my right to obtain separate legal counsel with respect to the negotiation and execution of this Agreement and
acknowledge that Bell, Boyd & Lloyd LLP has recommended that I retain my own counsel for such purpose. I further acknowledge that I (i) have read and understand this Agreement and its exhibits; (ii) have had the opportunity to
retain separate counsel in connection with the negotiation and execution of this Agreement; and (iii) have relied on the advice of separate counsel with respect to this Agreement or made the conscious decision not to retain counsel in
connection with the negotiation and execution of this Agreement. 
  

 5 

 k. Counterparts. This Agreement may be executed in counterparts, each of which will be deemed an
original copy of this Agreement and all of which, when taken together, will be deemed to constitute one and the same agreement. The exchange of copies of this Agreement and of signature pages by facsimile transmission shall constitute effective
execution and delivery of this Agreement as to the parties and may be used in lieu of the original Agreement for all purposes. Signatures of the parties transmitted by facsimile shall be deemed to be their original signatures for all purposes.

 [Signatures on following page.] 
  

 6 

 My signature below signifies that I have read, understand and agree to this Agreement. 
  

	
	 /s/ Kenneth E. Wolf

	Kenneth E. Wolf

  

			
	ACCEPTED AND AGREED TO:
	
	 Natural Alternatives International, Inc.,
 a
Delaware corporation

		
	By:	 	 /s/ Randell Weaver

		 	Randell Weaver, President

  

 7 

 EXHIBIT A 
 California Labor Code 
 § 2870. Invention on Own Time-Exemption from Agreement. 
 (a) Any provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to
his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer’s equipment, supplies, facilities, or trade secret information expect for those inventions that either:

 (1) Relate at the time of conception or reduction to practice of the invention to the employer’s business, or actual or demonstrably
anticipated research or development of the employer; or 
 (2) Result from any work performed by the employee for the employer. 

(b) To the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from being required
to be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable. 
 § 2871. Restrictions on Employer
for Condition of Employment. 
 No employer shall require a provision made void or unenforceable by Section 2870 as a condition of
employment or continued employment. Nothing in this article shall be construed to forbid or restrict the right of an employer to provide in contracts of employment for disclosure, provided that any such disclosures be received in confidence, of all
of the employee’s inventions made solely or jointly with others during the period of his or her employment, a review process by the employer to determine such issues as may arise, and for full title to certain patents and inventions to be in
the United States, as required by contracts between the employer and the United States or any of its agencies. 
  

 1 

 EXHIBIT B 
 Except as set forth below, Employee represents to the Company that there are no other contracts to assign Inventions now in existence between Employee and any other person or entity (see Section l(d) of the
Agreement): 
  

 1 

 EXHIBIT C 
 Set forth below is a brief description of all Inventions made or conceived by Employee prior to Employee’s employment with the Company, which Employee desires to be excluded from this Agreement (see Section l(d)
of the Agreement): 
  

 1 

 ATTACHMENT #3 
 FORM OF 
 SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS 
 This Separation Agreement and General Release of Claims (“Agreement”) is entered into by and between Kenneth E. Wolf (“Former
Employee”) and Natural Alternatives International, Inc., a Delaware corporation (“Company”). 
 RECITALS 
 A. Former Employee’s employment with the Company terminated effective on
                    . 
 B. Former
Employee and Company desire to settle and compromise any and all possible claims between them arising out of their relationship to date, including Former Employee’s employment with the Company, and the termination of Former Employee’s
employment with the Company, and to provide for a general release of any and all claims relating to Former Employee’s employment and its termination. 
 NOW, THEREFORE, incorporating the above recitals, and for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows: 
 AGREEMENT 
 1. Separation Payment
by Company. In consideration of Former Employee’s promises and covenants contained in this Agreement: 
 a. Company will, within ten
business days following the Effective Date of this Agreement, pay to Former Employee the sum of
                                        
and     /100 dollars ($            ), which amount represents one-half of the amount of separation pay due Former Employee, less all applicable
withholdings and deductions. The balance of separation pay shall be paid on a bi-weekly basis through the remaining severance period ending
                    . Former Employee acknowledges and agrees he has received payment for all unused accrued vacation pay as well as all
salary to which he was entitled through the Effective Date of this Agreement, less usual deductions. 
 b. Former Employee shall be entitled
to receive continuing group health insurance coverage pursuant to COBRA and Company will pay the next              (    ) months’ premiums for such
continuation coverage. 
 2. Release. 
 (a) Former Employee does hereby unconditionally, irrevocably and absolutely release and discharge the Company and its subsidiaries and affiliates, and its and their respective 

  

 1 

 
directors, officers, employees, volunteers, agents, attorneys, stockholders, insurers, successors and/or assigns, from any and all losses, liabilities,
claims, demands, causes of action, or suits of any type, whether in law and/or in equity, related directly or indirectly or in any way in connection with any transaction, affairs or occurrences between them to date, including, but not limited to,
Former Employee’s employment with the Company and the termination of said employment. Former Employee agrees and understands that this Agreement applies, without limitation, to all wage claims, tort and/or contract claims, claims for wrongful
termination, and claims arising under Title VII of the Civil Rights Act of 1991, the Americans with Disabilities Act, the Age Discrimination in Employment Act, the Equal Pay Act, the California Fair Employment and Housing Act, the Fair Labor
Standards Act, the Family and Medical Leave Act, the California Labor Code, any and all federal or state statutes or provisions governing discrimination in employment, and the California Business and Professions Code. 
 (b) Former Employee irrevocably and absolutely agrees that Former Employee will not prosecute nor allow to be prosecuted on Former Employee’s behalf
in any administrative agency, whether federal or state, or in any court, whether federal or state, any claim or demand of any type related to the matters released above, it being an intention of the parties that with the execution by Former Employee
of this Agreement, the Company and its subsidiaries and affiliates and its and their respective officers, directors, employees, volunteers, agents, attorneys, stockholders, successors and/or assigns will be absolutely, unconditionally and forever
discharged of and from all obligations to or on behalf of Former Employee related in any way to the matters discharged herein. 
 3.
Confidentiality. 
 (a) Former Employee agrees that all matters relative to this Agreement shall remain confidential. Accordingly,
Former Employee hereby agrees that Former Employee shall not discuss, disclose or reveal to any other persons, entities or organizations, whether within or outside of the Company, with the exception of Former Employee’s legal counsel,
financial, tax and business advisors, and such other persons as may be reasonably necessary for the management of the Former Employee’s affairs, the terms, amounts and conditions of settlement and of this Agreement. Notwithstanding the above,
Former Employee acknowledges that Company may be required to disclose certain terms, aspects or conditions of this Agreement and/or Former Employee’s termination of employment in the Company’s public filings made with the United States
Securities and Exchange Commission and Former Employee hereby expressly consents to any such required disclosures. 
 (b) Former Employee
shall not make, issue, disseminate, publish, print or announce any news release, public statement or announcement with respect to these matters, or any aspect thereof, the reasons therefore and the terms or amounts of this Agreement. 
 4. Return of Documents and Equipment. Former Employee represents that Former Employee has returned to the Company all Company Property (as such
term is defined in that certain Confidential Information and Invention Assignment Agreement, Covenant of Exclusivity and Covenant Not To Compete by and between Former Employee and Company). In the event Former Employee has not returned all Company
Property, Former Employee agrees to reimburse the Company for any reasonable expenses it incurs in an effort to have such property returned. These reasonable expenses include attorneys’ fees and costs. 
  

 2 

 5. Civil Code Section 1542 Waiver. 
 (a) Former Employee expressly accepts and assumes the risk that if facts with respect to matters covered by this Agreement are found hereafter to be
other than or different from the facts now believed or assumed to be true, this Agreement shall nevertheless remain effective. It is understood and agreed that this Agreement shall constitute a general release and shall be effective as a full and
final accord and satisfaction and as a bar to all actions, causes of action, costs, expenses, attorneys’ fees, damages, claims and liabilities whatsoever, whether or not now known, suspected, claimed or concealed pertaining to the released
claims. Former Employee acknowledges that Former Employee is familiar with California Civil Code §1542, which provides and reads as follows: 
 “A general release does not extend to claims which the creditor does not know of or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the
debtor.” 
 (b) Former Employee expressly waives and relinquishes any and all rights or benefits which Former Employee may have
under, or which may be conferred upon Former Employee by the provisions of California Civil Code §1542, as well as any other similar state or federal statute or common law principle, to the fullest extent that Former Employee may lawfully waive
such rights or benefits pertaining to the released claims. 
 6. OWBPA Provisions. In the event Former Employee is forty
(40) years old or older, in accordance with the Older Workers’ Benefit Protection Act of 1990, Former Employee is aware of and acknowledges the following: (i) Former Employee has the right to consult with an attorney before signing
this Agreement and has done so to the extent desired; (ii) Former Employee has twenty-one (21) days to review and consider this Agreement, and Former Employee may use as much of this twenty-one (21) day period as Former Employee
wishes before signing; (iii) for a period of seven (7) days following the execution of this Agreement, Former Employee may revoke this Agreement, and this Agreement shall not become effective or enforceable until the revocation period has
expired; (iv) this Agreement shall become effective eight (8) days after it is signed by Former Employee and the Company, and in the event the parties do not sign on the same date, this Agreement shall become effective eight (8) days
after the date it is signed by Former Employee. 
 7. Entire Agreement. The parties declare and represent that no promise, inducement
or agreement not herein expressed has been made to them and that this Agreement contains the entire agreement between and among the parties with respect to the subject matter hereof, and that the terms of this Agreement are contractual and not a
mere recital. This Agreement supersedes any and all other agreements, either oral or in writing, between the parties with respect to the subject matter hereof. 
  

 3 

 8. Applicable Law. This Agreement is entered into in the State of California. The validity,
interpretation, and performance of this Agreement shall be construed and interpreted according to the laws of the State of California. 
 9.
Agreement as Defense. This Agreement may be pleaded as a full and complete defense and may be used as the basis for an injunction against any action, suit or proceeding which may be prosecuted, instituted or attempted by either party in
breach thereof. 
 10. Severability. If any provision of this Agreement, or part thereof, is held invalid, void or voidable as against
public policy or otherwise, the invalidity shall not affect other provisions, or parts thereof, which may be given effect without the invalid provision or part. To this extent, the provisions, and parts thereof, of this Agreement are declared to be
severable. 
 11. No Admission of Liability. It is understood that this Agreement is not an admission of any liability by any person,
firm, association or corporation. 
 12. Counterparts. This Agreement may be executed in counterparts, each of which will be deemed an
original copy of this Agreement and all of which, when taken together, will be deemed to constitute one and the same agreement. The exchange of copies of this Agreement and of signature pages by facsimile transmission shall constitute effective
execution and delivery of this Agreement as to the parties and may be used in lieu of the original Agreement for all purposes. Signatures of the parties transmitted by facsimile shall be deemed to be their original signatures for all purposes.

 13. Representation of No Assignment. The parties represent and warrant that they have not heretofore assigned, transferred,
subrogated or purported to assign, transfer or subrogate any claim released herein to any person or entity. 
 14. Cooperation. The
parties hereto agree that, for their respective selves, heirs, executors and assigns, they will abide by this Agreement, the terms of which are meant to be contractual, and further agree that they will do such acts and prepare, execute and deliver
such documents as may reasonably be required in order to carry out the objectives of this Agreement. 
 15. Arbitration. Any dispute
arising out of or relating to this Agreement shall be resolved pursuant to that certain Mutual Agreement to Mediate and Arbitrate Claims made and entered into effective as of February 11, 2008, by and between the Company and Former Employee.

 17. Legal Representation; Independent Counsel. The law firm of Bell, Boyd & Lloyd LLP has prepared this Agreement
on behalf of the Company based on the Company’s instructions. Bell, Boyd & Lloyd LLP does not represent any other party to this Agreement. In executing this Agreement, Former Employee represents that Former Employee has neither
requested nor been given legal advice or counsel by Bell, Boyd & Lloyd LLP or any of its attorneys. Former Employee is aware of Former Employee’s right to obtain separate legal counsel with respect to the negotiation and execution of
this Agreement and acknowledges that Bell, Boyd & Lloyd LLP has recommended that Former Employee retain Former Employee’s own counsel for such purpose. Former Employee 

  

 4 

 
further acknowledges that Former Employee (i) has read and understands this Agreement; (ii) has had the opportunity to retain separate counsel in
connection with the negotiation and execution of this Agreement; and (iii) has relied on the advice of separate counsel with respect to this Agreement or made the conscious decision not to retain counsel in connection with the negotiation and
execution of this Agreement. 
 18. Further Acknowledgements. Each party represents and acknowledges that it is not being influenced
by any statement made by or on behalf of the other party to this Agreement. Former Employee and the Company have relied and are relying solely upon his, her or its own judgment, belief and knowledge of the nature, extent, effect and consequences
relating to this Agreement and/or upon the advice of their own legal counsel concerning the consequences of this Agreement. 
 IN WITNESS
WHEREOF, the undersigned have executed this Agreement on the date(s) shown below. 
  

			
	 FORMER EMPLOYEE

	
	  

	Kenneth E. Wolf

			
		
	 Dated:
	 	  

			
		
	 Executed in:
	 	                                     , California

		 	                 (City)

	
	 COMPANY

	
	 Natural Alternatives International, Inc.,
 a Delaware corporation

			
		
	 By:
	 	  

		 	 (Signature)

			
		
	 Printed Name:
	 	  

			
		
	 Title:
	 	  

			
		
	 Dated:
	 	  

			
		
	 Executed in:
	 	                                     , California

		 	                 (City)

  

 5Agreement and Plan of Reorganization

 Exhibit 10.1 
 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant
to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange Commission. 
 Agreement and Plan of Reorganization 
 AGREEMENT AND PLAN OF REORGANIZATION, dated as of February 9, 2008, by and among
VCG Holding Corp., a Colorado corporation (“Parent”), (*NAME CONFIDENTIAL*), a (*STATE CONFIDENTIAL*) limited liability company and a wholly-owned entity of Parent (“Sub”), (*NAME CONFIDENTIAL*), Inc., a (*STATE CONFIDENTIAL*)
corporation (the “Target”) (Sub and Target being hereinafter collectively referred to as the “Constituent Companies”) and (*NAME CONFIDENTIAL*) (“Controlling Shareholder”). 
 RECITALS 
 A. The Boards of Directors
and/or Members of Parent, Sub and Target have approved the acquisition of Target by Parent. 
 B. The Boards of Directors and/or Members of
Parent, Sub and Target have approved the merger of Target into Sub (the “Merger”), pursuant to the Agreement of Merger set forth in Schedule B hereto (“Agreement of Merger”) and the transactions contemplated hereby, in accordance
with the applicable provisions of the statutes of the States of (*STATE CONFIDENTIAL*) and Colorado which permit such Merger. 
 C. For
federal income tax purposes, it is intended that the Merger shall qualify as reorganization with the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended (the “Code”). 
 D. Each of the parties to this Agreement desires to make certain representations, warranties and agreements in connection with the Merger and also to
prescribe various conditions thereto. 
 AGREEMENT 
 Therefore, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 
 ARTICLE I 
 THE MERGER 
 1.1 The Merger. At the Effective Time (as defined in Section 1.2) and subject to the terms and conditions of this Agreement and the Agreement of Merger,
Target shall be merged into Sub and the separate existence of Target shall thereupon cease, in accordance with the applicable provisions of the (*STATE CONFIDENTIAL*) Business Corporation Act of the State of (*STATE CONFIDENTIAL*) (the “(*NAME
CONFIDENTIAL*)”) and the (*STATE CONFIDENTIAL*) Limited Liability Company Act (the “(*NAME CONFIDENTIAL*)”) and the Colorado Business Corporation Act of the State of Colorado (the “CBCA”). 
 (b) Sub will be the Surviving Company in the Merger (sometimes referred to herein as the “Surviving Company”) and will continue to be governed
by the laws of the State of (*STATE CONFIDENTIAL*), and the separate corporate existence of Sub and all of its rights, privileges, immunities and franchises, public or private, and all its duties and liabilities as a corporation organized under the
(*NAME CONFIDENTIAL*), will continue unaffected by the Merger. 
 (c) The Merger will have the effects specified by the (*NAME CONFIDENTIAL*)
and the CBCA. 
 1.2 Effective Time. As soon as practicable following fulfillment or waiver of the conditions specified
in Article VII and Article VIII hereof, and provided that this Agreement has not been terminated or abandoned pursuant to Article IX hereof, the Constituent Companies will cause a Certificate of Merger (the “Certificate of 

  

 Kdills/vcg/(*NAME CONFIDENTIAL*)/reorg plan redlined.doc 
 MAG - V.8 FINAL 
 2/9/08 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 
Merger”) and, if necessary, Articles of Merger (the “Articles of Merger”) to be filed with the office of the Secretary of State of the State
of (*STATE CONFIDENTIAL*) and comply with all requirements for a merger as provided in the (*NAME CONFIDENTIAL*) and (*NAME CONFIDENTIAL*), and will cause the Agreement of Merger together with a duly executed Certificate of Approval of Merger and,
if necessary, Articles of Merger, certificates of the officers of Parent and the Constituent Companies and tax clearance certificates to be filed with the office of the Secretary of State of the State of Colorado, as required by the CBCA. Subject to
and in accordance with the laws of the States of (*STATE CONFIDENTIAL*) and Colorado, the Merger will become effective at the date and time the Certificate of Merger and, if necessary, Articles of Merger, is filed with the office of the Secretary of
State of the State of (*STATE CONFIDENTIAL*) or such later time or date as may be specified in the Certificate of Merger and/or Articles of Merger (the “Effective Time”). Each of the parties will use its best efforts to cause the Merger to
be consummated as soon as practicable following the fulfillment or waiver of the conditions specified in Articles VII and VIII hereof. 
 ARTICLE II 
 THE SURVIVING COMPANY 
 2.1 Articles of Organization. The Articles of Organization of Sub as in effect immediately prior to the Effective Time shall be the Articles of Organization of
the Surviving Company after the Effective Time. 
 2.2 Operating Agreement. The Operating Agreement of Sub as in effect
immediately prior to the Effective Time shall be the Operating Agreement of the Surviving Company after the Effective Time. 
 2.3
Managers. From and after the Effective Time, the Managers of Sub shall be the Managers of the Surviving Company. 
 ARTICLE III 
 CONVERSION OF SHARES 
 3.1 Conversion of Target Shares in the Merger. Pursuant to the Agreement of Merger, at the Effective Time, by virtue of the Merger and without any action on the part of any holder of any capital
stock of Target: 
 (a) all shares of Common Stock of Target (“Target Common Stock”) owned by Parent or any subsidiary of Parent or
Target shall be cancelled and shall cease to exist from and after the Effective Time; and 
 (b) each remaining issued and outstanding share
of Target Common Stock shall, subject to Section 3.3(e) hereof, be converted into, and become exchangeable for, the number of shares of validly issued, fully paid and nonassessable common stock, without par value, of Parent (“Parent Common
Stock”) equal to the Conversion Ratio. In this Agreement, the term “Conversion Ratio” means a fraction, whereby the Numerator is equal to (i) 50% of the Purchase Price, as set forth in Section 3.4, divided by the Per
Share Price which is (ii) the 10-day volume weighted average closing sale price (determined as set forth in Schedule 3.1(b)) of a share of Parent Common Stock as reported on NASDAQ under the trading symbol “VCGH” (the “Average
Price”) for the 10 trading days immediately preceding the day which is 1 calendar day prior to the date of execution of this Agreement but in no event less than $11.00 per share and the Denominator which is equal to the sum of the number
of shares of Target Common stock issued and outstanding as of the date of this Agreement. The consideration referred to in this Section 3.1, together with any cash payments in lieu of fractional shares as provided herein, is hereinafter
referred to as the “Merger Consideration.”. 
 3.2 Status of Sub Shares. At the Effective Time, by virtue of
the Merger and without any action on the part of any holder of any membership interest of Sub, each issued and outstanding interest of Sub shall continue unchanged and remain outstanding as a share of common stock of the Surviving Company.

 3.3 Exchange of Company Capital Stock Certificates. (a) On or prior to the Closing Date, Parent shall make
available to the Escrow Agent the certificates representing shares of Parent Common Stock required to effect the exchange referred to in Section 3.3(b). Parent shall also make available to the Escrow Agent the cash required as set forth in 3.5
below and to make the cash payments in lieu of fractional shares referred to in Section 

  

 2 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 
3.3(e) below. Shares of Parent Common Stock into which shares of Target Common Stock shall be converted in the Merger shall be deemed to have been issued at
the Effective Time. 
 (b) From and after the Effective Time, each holder of a certificate which immediately prior to the Effective Time
represented outstanding shares of Target Common Stock are granted by reason of the Merger under the CBCA shall be entitled to receive in exchange therefor upon surrender thereof to (*NAME AND ADDRESS CONFIDENTIAL*) (the “Escrow Agent”), a
certificate or certificates representing the number of whole shares of Parent Common Stock into which such holder’s shares of Target Common Stock were converted pursuant to Section 3.1 and cash in lieu of any fractional shares of such
Parent Common Stock pursuant to Section 3.3(e) plus that portion of the cash set forth in 3.5 below as represented by each shareholder of shares surrendered of the total shares of Target set forth as to the Denominator in 3.1(b) above. From and
after the Effective Time, Parent shall be entitled to treat the certificates which immediately prior to the Effective Time represented shares of Target Common Stock and which have not yet been surrendered for exchange as evidencing the ownership of
the number of full shares of Parent Common Stock into which the shares of Target Common Stock represented by such certificates shall have been converted pursuant to Section 3.1, notwithstanding the failure to surrender such certificates.
However, notwithstanding any other provision of this Agreement, until holders or transferees of certificates which immediately prior to the Effective Time represented shares of Target Common Stock have surrendered them for exchange as provided
herein, no dividends shall be paid with respect to any shares represented by such certificates and no payment for fractional shares shall be made. Upon surrender of a certificate which immediately prior to the Effective Time represented outstanding
shares of Target Common Stock, there shall be paid to the holder of such certificate the amount of any dividends which theretofore became payable, but which were not paid by reason of the foregoing, with respect to the number of whole shares of
Parent Common Stock represented by the certificate or certificates issued upon such surrender. If any certificate for shares of Parent Common Stock is to be issued in a name other than that in which the certificate, which immediately prior to the
Effective Time represented shares of Target Common Stock, surrendered in exchange therefor is registered, it shall be a condition of such exchange that the person requesting such exchange shall pay any transfer or other taxes required by reason of
the issuance of certificates for such shares of Parent Common Stock in a name other than that of the registered holder of any such certificate surrendered. 
 (c) Intentionally Left Blank 
 (d) As soon as practicable after the Effective Time, the Escrow Agent shall
mail to each holder of record of a certificate or certificates that immediately prior to the Effective Time represented outstanding shares of Target Common Stock (collectively, the “Target Certificates”) (i) a form letter of
transmittal (which shall specify that delivery shall be effected, and risk of loss and title to Target Certificates shall pass, only upon actual delivery of Target Certificates to the Escrow Agent) and (ii) instructions for use in effecting the
surrender of Target Certificates in exchange for certificates representing shares of Parent Common Stock. Upon surrender of Target Certificates for cancellation to the Escrow Agent, together with a duly executed letter of transmittal and such other
documents as the Escrow Agent shall require, the holder of such Target Certificates shall be entitled to receive in exchange therefor a certificate representing that number of whole shares of Parent Common Stock into which the shares of Target
Common Stock represented by Target Certificates so surrendered shall have been converted pursuant to the provisions of Section 3.1, and Target Certificates so surrendered shall forthwith be cancelled. Notwithstanding the foregoing, neither the
Escrow Agent nor any party hereto shall be liable to a holder of shares of Target Common Stock for any shares of Parent Common Stock or dividends or distributions thereon delivered to a public official pursuant to applicable escheat laws.

 (e) Notwithstanding any other provision of this Agreement or the Agreement of Merger, no certificates or scrip for fractional shares of
Parent Common Stock shall be issued upon the surrender for exchange of Target Certificates pursuant to this Article III in the Merger or upon any exchange made pursuant to Section 4.4 hereof and no Parent Common Stock dividend, stock split or
interest shall relate to any fractional security, and such fractional interests shall not entitle the owner thereof to vote or to any other rights of a security holder. In lieu of any such fractional shares, each holder of Target Common Stock and
each Optionholder who has executed an Option Termination Agreement under Section 4.4 hereof who would otherwise have been entitled to a fraction of a share of Parent Common Stock (i) upon surrender of Target Certificates for exchange
pursuant 

  

 3 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 
to this Article III, or (ii) pursuant to Section 4.4 hereof, as applicable, shall be entitled to receive from the Escrow Agent a cash payment in
lieu of such fractional share equal to such fraction multiplied by the Per Share Price set forth at 3.1(b)(ii). 
 (f) (i) After
the Effective Time and the Closing, at the expiration of one (1) year but not prior thereto, and within 10 days and not thereafter (the “Put Period”), the Target Shareholders, or in the event the shares acquired herein (the
“Merger Shares” which is the number of shares in the Numerator as set forth in 3.1(b)) have been transferred by the Target Shareholders to a Purchasing Shareholder (collectively hereafter the “New Shareholders”) shall have the
right to give notice to Parent of their desire to surrender their remaining Merger Shares herein thereafter (the “Put Shares”) for a minimum price per share (the “Put Price”), determined by dividing the Total Put Price by the Put
Shares, as determined in accordance with the following formula: 
 Formula for the “Total Put Price” 
 Total Put Price, defined as the Net Earnings as set forth in Section 3.4 x 3.190909 less 50% of the Purchase Price as set forth in
Section 3.4. 
 (Example: Assumed facts: 
  

	 	1.	Net Earnings $5,500,000 

  

	 	2.	Purchase Price $20,300,000 

 The Total Put Price is
$7,400,000. 
 ($5,500,000 x 3.190909) - $10,150,000 = $7,400,000) 
 provided, however, the sum of any of the Merger Shares that are sold during the Put Period shall be reduced from the Total Put Price; further provided, however, if Parent’s Average Price per share is equal to or
greater than the Termination Price during the Put Period, as determined in the formula below: 
 Formula for the “Termination
Price” 
 The Termination Price is defined as the Net Earnings set forth in Section 3.4 multiplied by 4.690909
less the cash received as set forth in Section 3.5 divided by the Merger Shares, the Put Provision shall be terminated subject to the Lock-Out Period provisions and the formula set forth herein. 
 (Example 
 The Net
Earnings are $5,500,000. The cash received was $10,150,000. The Merger Shares are 922,727. [($5,500,000 x 4.690909) - $10,150,000] - 922,727 = $16.96 Per Share.) 
 then, any of the Merger Shares not sold at the Termination Price below the 50,000 shares that could have been sold free of the Lock-Up Provision set forth in Section 3.3(g) during Months 4 through 12 of the
Put Period shall be treated as having been sold at the Termination Price, which sum shall reduce the Total Put Price. 
  

 4 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 [This space intentionally left blank.] 
  

 5 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 An Example of the calculation of (f)(i) above is as follows: 
 (Example 
 Assume the following facts:

  

			
	1.	  	922,727 Merger Shares
		
	2.	  	Termination Price is attained during 3 months of the Put Period between the 4th and 12th month of the Put Period.
		
	3.	  	70,000 Merger Shares sold at or above the Termination Price for a sum of $1,330,000 (an average price of $19 per share) during the Put Period.
		
	4.	  	100,000 shares sold below the Termination Price for a total of $1,100,000
		
	5.	  	Termination Price is $16.96
		
	6.	  	Total Put Price is $7,400,000

 Based on the facts as stated above, the Put Shares may be surrendered to the Parent at $5.37 per
share (the Put Price), calculated as follows: 
  

					
	1.	  	$ 7,400,000	  	Total Put Price (see 6 above) for purposes of the Put Provision
			
	2.	  	($1,330,000)	  	The total sales price of 70,000 Merger Shares sold at or above the Termination Price (average price of $19 per share) (see #3 above)
			
	3.	  	($1,356,800)	  	The value of the Merger Shares not sold which could have been sold during the 3 months of the Put Period when the Average Price was equal to or greater than the Termination Price
(the New Shareholders could have sold 150,000 Merger Shares during said period but only sold 70,000 Merger Shares) (150,000 - 70,000 x $16.96)
			
	4.	  	($1,100,000)	  	The value of the 100,000 Merger Shares sold by the New Shareholders during the Put Period below the Termination Price (average price of $11.00 per share) (see #4 above)
			
	5.	  	$ 3,613,200	  	Total amount due for the Put Shares which is now the reduced total Put Price
			
	6.	  	922,727	  	Total Merger Shares
			
	7.	  	(70,000)	  	Sold in #2 above
			
	8.	  	(80,000)	  	Could have been sold in #3 above
			
	9.	  	(100,000)	  	Sold in #4 above
			
		  	672,727	  	Total Put Shares (total remaining Merger Shares not sold or deemed sold)
		
	10.	  	3,613,200 ÷ 672,727 = $5.37 per share)

  

 6 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 (ii) In the event the New Shareholders shall elect to exercise their rights pursuant to the Put Provision, Parent
shall have ninety (90) days from receipt of said notice to pay the New Shareholders such Put Price times the number of Put Shares surrendered, with interest at 10% per annum to be paid from the date of such notice until paid in full.
During the Put Period, as set forth in the Put Provision, the Parent agrees to reserve a sum equal to the Total Put Price, as defined above, in twelve (12) equal installments in order to have available funds to pay the New Shareholders should
they exercise their rights pursuant to the Put Provision, with no interest thereon; provided, however, that upon the Termination of the Put Provision or reduction of the Total Put Price, the Parent shall no longer be required to reserve said sums in
excess of the Total Put Price, as reduced. 
 (iii) Any shares transferred pursuant to the Put Provision will be transferred free and clear of all liens and
encumbrances and the New Shareholders will execute all documents necessary to convey same as set forth herein. 
 (iv) The Put Provision shall be attached to
said shares received pursuant to this Agreement and shall not be separate from said shares. 
 (g) The New Shareholders’ shares which
are the subject of this Agreement shall be the subject of the Lock-Up Agreement as set forth on Schedule 3.3(g) (the “Lock-Up Provision”). 
 (h) The shares transferred pursuant to this Plan shall be legended to contain the provisions set forth in Sections 3.3(f) and (g), as shown in Schedule 3.3(h). The legend, Put Provision, and Lock-Up Provision shall be
removed as and when said shares shall be sold in the open market. 
 3.4 Purchase Price. The Purchase Price shall be the
product rounded to the nearest dollar of 3.690909 times the Net Earnings of the Target calculated in accordance with GAAP consistently applied for the previous successive twelve (12) months prior to the execution of this Agreement. [For
example: Assuming the prior 12 months Net Earnings are $5,500,000, the Purchase Price shall be $20,300,000. ($5,500,000 x 3.690909). 
 3.5
Cash Portion of Purchase Price. Fifty (50%) Percent of the Purchase Price rounded to the nearest dollar as set forth in Section 3.4 above shall be paid in cash at the Closing. 
 3.6 Closing of Transfer Books. From and after the Effective Time, the stock transfer books of Target shall be closed and no transfer
of shares of Target Common Stock shall thereafter be made. If, after the Effective Time, Target Certificates are presented to Parent, they shall be cancelled and exchanged for the Merger Consideration in accordance with the procedures set forth in
this Article III. 
 3.7 Closing. The closing (the “Closing”) of the transactions contemplated by this
Agreement shall take place (a) at the offices of Target’s counsel at 10:00 a.m., local time, on the earlier of (i) May 1, 2008, but not before the conditions set forth in Articles VII and VIII are fulfilled or waived and
(ii) the third business day immediately following the date on which the last of the conditions set forth in Articles VII and VIII hereof are fulfilled or waived, or (b) at such other time and place and on such other date as Parent and
Target shall agree (the “Closing Date”). 
 ARTICLE IV 
 FURTHER AGREEMENTS 
 4.1 Transition Period. Controlling Shareholder and (*NAME
CONFIDENTIAL*) hereby covenant that they shall from the Closing and for one hundred twenty (120) consecutive days thereafter assist Sub in every reasonable manner in the transition of the day-to-day operations of the Target. The assistance
shall include, but not be limited to, physical presence at the Target facility, and good faith activities including phone calls, face to face meetings, and other such activities to assist Sub in the transition for one hundred twenty (120) days
immediately after the Closing. 
  

 7 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 4.2 Non-Competition Agreement. At or prior to the Closing, (i) Controlling
Shareholder and (*NAME CONFIDENTIAL*) shall execute non-competition agreements (the “Covenants Not to Compete”) in the form attached as Schedule 4.2(a) and 4.2(b) hereto. 
 4.3 Delivery into Escrow. The parties agree to execute the Escrow Agreement as attached hereto on Schedule 4.3 and to allow (*NAME
CONFIDENTIAL*) to act as Escrow Agent according to the terms set forth therein. 
 4.4 Options. On or prior to the
Closing, Target and Controlling Shareholder shall obtain the agreement (“Option Termination Agreements”), in substantially the form attached hereto as Schedule 4.4, of each of the holders (“Option-holders”) of outstanding options
(“Options”) to purchase Target Common Stock listed in Schedule 5.3(c), to the termination of the Options held by such Optionholder upon the Merger in consideration for the receipt, promptly following the Effective Time, of a number of
shares of Parent Common Stock equal to (a) the product of (i) the Conversion Ratio, and (ii) the number of shares of Target Common Stock subject to each such Option held by such Optionholder, minus (b) the number of shares
of Target Common Stock subject to each such Option held by such Optionholder, multiplied by the exercise price of the Option, divided by the Valuation Price. Cash payments in lieu of fractional shares will be made in the manner
provided for in Section 3.3(e) hereof. 
 4.5 Post-Closing Adjustments. (a) For the purpose of this Agreement,
the “Net Book Value” shall be the amount by which the aggregate book amount of the total assets of Target and its subsidiaries on a consolidated basis at the Effective Time, as determined in accordance with this Section 4.5 and as
shown on the Closing Balance Sheet (as hereinafter defined in Section 4.5(b)) exceeds the aggregate book amount of the total liabilities of Target and its subsidiaries on a consolidated basis at the Effective Time, as determined in accordance
with this Section 4.5 and as shown on the Closing Balance Sheet. 
 (b) The Net Book Value shall be determined in U.S. Dollars from
statements of total assets and total liabilities of Target and its subsidiaries on a consolidated basis as of the Effective Time (the “Closing Balance Sheet”). The Closing Balance Sheet shall be prepared by Controlling Shareholder and
audited at the Surviving Company’s expense. The inventory of Target and its subsidiaries on a consolidated basis shall be determined pursuant to a physical count, or such other procedures as may be mutually agreed upon. 
 (c) For the purpose of this Agreement, the Net Earnings (“Net Earnings”), as set forth in Section 3.4 hereof, for the previous twelve
(12) successive months shall be recalculated in accordance with GAAP so as to allow for a verification of the Purchase Price, as used herein (“Closing Net Earnings”). 
 (d) The Closing Balance Sheet and the Closing Net Earnings shall be prepared in accordance with United States generally accepted accounting principles
(“GAAP”) applied on a basis consistent with those applied in the preparation of the Financial Statements (as defined in Section 5.3(h) hereof) (to the extent that the principles applied in the preparation thereof were in accordance
with GAAP) and auditing procedures will be carried out in accordance with generally accepted auditing standards or as Parent, Target and Controlling Shareholder have otherwise herein agreed. 
 (e) The parties shall cooperate in the preparation of the Closing Balance Sheet and the Closing Net Earnings and the compilation of the information to be
used in the preparation thereof, and shall use their respective best efforts to cause their respective accountants to make available to each other their respective work papers with respect to the Closing Balance Sheet and Closing Net Earnings. The
Closing Balance Sheet and Closing Net Earnings shall contain the draft opinion of the Target’s accountants, addressed to Parent and Target, which shall be unqualified. 
 (f) Controlling Shareholder shall use his best efforts to cause the Closing Balance Sheet and Closing Net Earnings to be delivered to Parent no later
than 75 days next following the Effective Time. 
 (g) Parent shall have forty five (45) days after receipt by it of the Closing Balance
Sheet and Closing Net Earnings (the “Dispute Period”) to dispute any of the elements of such Closing Balance Sheet and Closing Net Earnings (a “Dispute”). If Parent does not give written notice of a Dispute (a “Dispute
Notice”) to Controlling Shareholder within the Dispute Period, such Closing Balance Sheet and Closing Net Earnings shall be deemed to 

  

 8 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 
have been accepted by Parent in the form in which it was delivered by Controlling Shareholder and shall be final and binding upon the parties in the absence
of fraud or manifest error. In the event Parent does not agree with any amount or element reflected on the Closing Balance Sheet or Closing Net Earnings, Parent may give Controlling Shareholder a Dispute Notice within the Dispute Period, setting
forth in reasonable detail the elements and amounts with which it disagrees, and Controlling Shareholder and Parent shall, within thirty (30) days after receipt by Controlling Shareholder of such Dispute Notice, attempt to resolve such Dispute
and agree in writing upon the final content of such Closing Balance Sheet and Closing Net Earnings. In the event that Controlling Shareholder and Parent are unable to resolve any such Dispute within such thirty (30) day period, then the
certified public accounting firm of (*NAME AND ADDRESS CONFIDENTIAL*) [a third accounting firm] (the “Arbitrating Accountant”) shall be employed as arbitrator hereunder to settle such Dispute as soon as practicable. In connection with the
resolution of any Dispute, the Arbitrating Accountant shall have access to all documents and facilities necessary to perform its functions as arbitrator. The Arbitrating Accountant’s function shall be to conform the Closing Balance Sheet and
Closing Net Earnings to the standards required by the terms and provisions of this Section 4.5. The Arbitrating Accountant’s determination with respect to any Dispute shall be final and binding upon the parties hereto. Controlling
Shareholder and Parent shall each pay one-half of the fees and expenses of the Arbitrating Accountant. Following the resolution of any Disputes, the Closing Balance Sheet and Closing Net Earnings shall be revised to reflect such resolution.
Following such resolution, or, if there are no Disputes, following the expiration of the Dispute Period, Controlling Shareholder shall cause the Closing Balance Sheet and Closing Net Earnings, containing the signed unqualified opinion of
Target’s accountants, to be issued and delivered to Parent. 
 (h) In the event
the Net Book Value is less than $50,000.00 from the Statements as presented by Target, then Parent shall, as soon as is practicable after the delivery in final form to Parent of the Closing Balance Sheet in accordance with Section 4.5 hereof,
make a written demand on Controlling Shareholder for the amount by which the actual Net Book Value is less than $50,000.00 from the Statements as presented by the Target and such amount shall be paid by Controlling Shareholder to Parent by one-half
( 1/2) of said amount being returned to Parent of the Parent Common Stock transferred herein pursuant to
Section 3.1(b), and the other one-half ( 1/2) of such amount after the release of such shares of Parent Common Stock
shall be paid by Controlling Shareholder to Parent in cash within three business days after the return of such shares of Parent Common Stock. Controlling Shareholder’s obligation to make payments pursuant to this Section 4.5 is independent
of, and in addition to, the indemnity obligations set forth in Article IX of this Agreement, and will not in any way be subject to the limitations referred to in Section 9.3 hereof. 
 (i) In the event the Purchase Price is less than the amount determined in Section 3.4, then
Parent shall, as soon as is practicable after the delivery in final form to Parent of the Closing Net Earnings in accordance with this Section 4.5 hereof, make a written demand on Controlling Shareholder for the amount by which the Purchase
Price is less than the Purchase Price as set forth in Section 3.4, calculated in the same manner, and such amount shall be paid by Controlling Shareholder to Parent by one-half ( 1/2) of said amount being returned to Parent of the Parent Common Stock transferred herein pursuant to Section 3.1(b), and the other one-half ( 1/2) of such amount after the release of such shares of Parent Common Stock shall be paid by Controlling Shareholder to Parent in
cash within three business days after the return of such shares of Parent Common Stock. Controlling Shareholder’s obligation to make payments pursuant to this Section 4.5 is independent of, and in addition to, the indemnity obligations set
forth in Article IX of this Agreement, and will not in any way be subject to the limitations referred to in Section 9.3 hereof. The repayment of the shares of Parent Common Stock and the cash due as set forth herein shall be calculated in the
same manner as provided for in this Agreement. 
 4.6 Fixed Asset Inventory. On or prior to the Closing
Date, Target will conduct an inventory of each of the fixed assets of Target and its subsidiaries with an individual net book value of $2000 or more, and there shall be at the time of Closing a minimum inventory valued at $10,000.00. 
 4.7 Special Permits. (*NAME CONFIDENTIAL*) holds at (*ADDRESS CONFIDENTIAL*) a Sexually Oriented Business license (“SOB
license”) issued under (*CODE CONFIDENTIAL) of the (*COUNTY CONFIDENTIAL*) City Code and Permits issued by the (*STATE CONFIDENTIAL*) Alcoholic Beverage Commission to sell and provide liquor for onsite consumption (“(*NAME CONFIDENTIAL*)
permit”)( collectively “special permits”). Said special permits are not transferable. 

  

 9 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 
The Parties hereto agree that they will cooperate with the issuing agencies whose consent is required to obtain the issuance of new special permits to the
Sub as survivor of the Merger hereunder prior to and as a condition of closing hereunder, provided (*NAME CONFIDENTIAL*) is not required to cancel or surrender its special permits until such time as this transaction closes and for the instantaneous
issuance of a SOB permit to the Sub. The Parties recognize that (*CODE CONFIDENTIAL) and the City of (*CITY CONFIDENTIAL*) require the cancellation of (*NAME CONFIDENTIAL*) SOB license at (*ADDRESS CONFIDENTIAL*) as a condition to issue a new SOB
license for the Sub at (*ADDRESS CONFIDENTIAL*) and such new license is effective when issued and must be picked up and paid for immediately upon issuance. Failure by the Sub to do so shall cause substantial damage to (*NAME CONFIDENTIAL*) and
Controlling Shareholder. Accordingly, the Parent and Sub warrant and represent they shall timely attempt to obtain such SOB license and the acceptance of such SOB license and the right granted by (*NAME CONFIDENTIAL*) to sell alcoholic beverages
under the same terms and conditions as the Target shall constitute an event of Closing. The Parties recognize the (*NAME CONFIDENTIAL*) permits may require the operation after Closing by Sub under (*NAME CONFIDENTIAL*) Permits with the permission of
the (*STATE CONFIDENTIAL*) Alcoholic Beverage Commission. The Parties shall fully cooperate with each other and the regulatory agencies/governmental entities referenced above to effectuate the issuance of new Special Permits contemplated hereunder.

 4.8 Articles of Merger. The Sub as the surviving (*STATE CONFIDENTIAL*) entity shall upon Closing file Articles of
Merger are provided in Exhibit 4.8, attached hereto and incorporated into this Plan at length, the same as if fully copied and set forth herein. 
 4.9 Certificates of Formation of Sub. The Sub, as the surviving (*STATE CONFIDENTIAL*) entity, Certificate of Formation are provided in Exhibit 4.9, attached hereto and incorporated into this Plan at length, the same as
if fully copied and set forth herein. 
 4.10 Shareholder Approval. This Plan will be submitted for approval separately
to the shareholders of the Sub and the Target in the manner provided by the laws of (*STATE CONFIDENTIAL*). 
 ARTICLE V 
 REPRESENTATIONS AND WARRANTIES 
 5.1
General Statement. The parties make the representations and warranties to each other which are set forth in this Article V. The survival of all such representations and warranties shall be in accordance with Section 10.1
hereof. All representations and warranties of the parties are made subject to the exceptions which are noted in the respective schedules delivered by the parties to each other concurrently herewith. 
 5.2 Representations and Warranties of Parent and Sub. Parent and Sub jointly and severally represent and warrant to Target, as of
the date hereof and at the Effective Time, and the Closing as follows: 
 (a) Parent and Sub are corporations or other legal entities duly
formed, validly existing and in good standing under the laws of the State of Colorado and (*STATE CONFIDENTIAL*), respectively. Both Parent and Sub have the requisite corporate power to execute and deliver this Agreement and to carry out the
transactions contemplated hereby. If necessary, the Parent and Sub are duly qualified as a foreign corporation in good standing in each jurisdiction in which the conduct of their business requires such qualification. 
  

 10 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 (b) The execution, delivery and performance by the Parent and Sub of this Agreement and the
transactions contemplated hereby are within the powers of the Parent and Sub and have been duly authorized by all necessary action. This Agreement constitutes a valid and binding obligation of the Parent and Sub, enforceable against the Parent and
Sub in accordance with its terms, subject to bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or other similar laws of general application affecting the enforcement of creditors’ rights generally. 
 (c) Prior to the performance by the Parent and Sub of this Agreement and the consummation of the transactions contemplated hereby, the Parent and Sub
shall have filed or will have obtained waivers in lieu of filing or have obtained the required approval of or given notice to any governmental or regulatory body, agency or official, as required, to consummate their obligations pursuant to this
Agreement, including but not limited to obtaining the License from the City of (*CITY CONFIDENTIAL*) pursuant to (*CITY CONFIDENTIAL*) City Code, Section (*CODE CONFIDENTIAL), allowing Parent and Sub to have the right to operate the business of
Target in the same manner and with the same rights as Target prior to the merger. 
 (d) Neither the execution, delivery and performance by
the Parent and Sub of this Agreement, nor the consummation of the transactions contemplated hereby, will violate, conflict with, or result in a breach of any provision of the charter or the articles of organization or by-laws or operating agreement
of the Parent or Sub or of any applicable law, regulation, rule, order, judgment, decree or writ of any foreign, federal, state or local governmental or regulatory authority or body or court. 
 (e) Neither the execution, delivery and performance by the Parent and Sub of this Agreement, nor the consummation of the transactions contemplated
hereby, will result in a default (or give rise to any penalty or give to any third party a right of termination, cancellation, acceleration or result in the creation of any material encumbrance) under any of the terms, conditions or provisions of
any material contract to which the Parent or Sub are a party or by which either of them is bound. 
 (f) Parent and Sub hereby warrant that
no broker, finder, or investment banker is entitled to any brokerage, finders or other fee of commission in connection with the transaction contemplated by this Agreement based upon arrangements made by or on behalf of the Parent or Sub. 

(g) Parent and Sub have made all required SEC filings and they contain no untrue statements. Parent and Sub represent that the transactions
contemplated herein and the sale/transfer of shares hereunder is in compliance with and will be compliant at the time of Closing with all applicable state and federal securities laws, including the Securities Act of 1933 and the Securities Exchange
Act of 1934. All actions will be taken to ensure that the Parent common stock issued hereunder to Controlling Shareholder will be registered under said laws and freely marketable (without restriction except in the Lockup Provision hereof). Parent
and Sub will timely file all necessary documents to ensure compliance with this representation, including all filings, forms, and notices required by the SEC, the stock exchange/index on which the stock is traded, Colorado, and (*STATE
CONFIDENTIAL*). 
 (h) Neither the Parent nor the Sub has suffered any adverse change in their business, operations, or financial conditions
nor become aware of any event which may result in any such adverse change. 
 (i) Parent and Sub have made no untrue statement or omission of
material fact in this Agreement, the Agreement of Merger or in any Registration Statements. 
 (j) In accordance with Article VII hereof, by
the date of the Closing, the Parent and Sub shall have reviewed the books and records of Target and have completed their Due Diligence and shall be satisfied with such Due Diligence inspection, or Parent and Sub shall have provided notice of any
deficiencies to Target in accordance with Article VII hereof. 
  

 11 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 (k) Parent and Sub understand the stock of (*NAME CONFIDENTIAL*) being acquired is not registered
with the SEC or the State of (*STATE CONFIDENTIAL*). The acquiring company, the Sub, is a bona fide (*STATE CONFIDENTIAL*) resident as a (*STATE CONFIDENTIAL*) limited liability company and domiciled in the State of (*STATE CONFIDENTIAL*). This
Agreement and Plan of Reorganization was executed by Sub and delivered to Sub in (*STATE CONFIDENTIAL*) solely. Sub intends that the (*NAME CONFIDENTIAL*) stock will cease to exist upon merger into Sub and Sub has no intent to divide, resell, or
otherwise distribute said stock among or to persons anywhere and, if so, not to persons not domiciled in the State of (*STATE CONFIDENTIAL*). 
 (l) (i) Securities Representations/Obligations. The Parent and Sub, on their behalf and on behalf of all predecessor corporations, represent that they are in good standing under all applicable federal and state
securities law, including but not limited to the Securities Act of 1993 as a amended (the “Securities Act”), the Securities Act of 1934 as amended (the “Exchange Act”) and the regulations promulgated thereunder and have filed all
requisite filings with the Securities and Exchange Commission or any other federal or state agencies and administrators, stock exchanges, and stock quotation and bulletin board services necessary for its continued existence and issuance, trading, or
marketing of its share (herein “Securities Facilitators”), including the shares contemplated to be delivered to Controlling Shareholder under this Plan. The Parent and Sub represent that they are not aware of any delinquency or late filing
notices from any Securities Facilitators, or any notice received from any other party notifying the Parent and/or Sub of imminent or pending investigation or review to be commenced against the Parent and/or Sub. The Parent and Sub represent that
there are no securities matters pertaining to them that is materially adverse to the value of their stock and this Plan. The Parent and Sub represent that this merger, acquisition or transaction, complies with the Exchange Act and the Securities Act
and that all actions related to registration, trading, and distribution of stock of the Parent and Sub contemplated hereunder have complied with all applicable federal and state securities law including the Exchange Act and the Securities Act. The
Parent and Sub shall hereby indemnify (*NAME CONFIDENTIAL*). and (*NAME CONFIDENTIAL*) from any violations of securities laws up and through and including the Effective Date of the Plan, including those to be done in contemplation of this Plan or to
effectuate same. 
 (ii) Plan/Securities and Exchange Commission Compliance. The parties to this merger warrant mutually
that they will follow all necessary procedure under the requirements of federal, Colorado, and (*STATE CONFIDENTIAL*) securities law and the related supervisory commissions to ensure this Plan is properly processed to comply with all federal and
state requirements to take full advantage of any lawful or applicable exemption for registration but that the responsibility for same and the costs for same shall be borne by Sub. 
 (iii) Registration of (*NAME CONFIDENTIAL*) Shares. 
 (a) Registration of (*NAME CONFIDENTIAL*) Shares. The Parent and Sub hereby agree to file, at their cost and expense, as soon as
reasonably practicable, but, in no event later than thirty (30) days from the Closing Date, a registration statement on Form S-3, if reasonably practicable, or on any appropriate form under the Securities Act with respect to all of (*NAME
CONFIDENTIAL*) Shares to be acquired hereunder (“(*NAME CONFIDENTIAL) shares”) (the “Registration Statement”). The Parent and Sub agree to use its best efforts to have the Registration Statement declared effective as soon as
reasonably practicable after such filing and to keep the Registration Statement continually effective for a period of two (2) years following the date on which the Registration Statement is declared effective by the Commission or until all
(*NAME CONFIDENTIAL*) Shares included in the Registration Statement can be publicly offered and sold without registration, whichever is earlier. 
 (b) Notice to (*NAME CONFIDENTIAL*). The Parent and Sub shall promptly notify (*NAME CONFIDENTIAL*) of the occurrence of any event as a result of which any prospectus included in a Registration Statement filed pursuant
to this Section 4 includes any misstatement of a material fact or 

  

 12 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 
omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then
existing. 
 (c) Limitations on Obligations of the Sub. The Parent and Sub’s obligations under this Section 4
with respect to (*NAME CONFIDENTIAL*) are expressly conditioned upon (*NAME CONFIDENTIAL*) promptly furnishing to the Parent and Sub, in writing, upon another request from the Parent and Sub, such information concerning (*NAME CONFIDENTIAL*) as the
Parent and Sub shall reasonably request for inclusion in the Registration Statement. If any Registration Statement, including the (*NAME CONFIDENTIAL*) Shares, is filed the Parent and Sub shall indemnify (*NAME CONFIDENTIAL*) (and each underwriter
for such holder and each person, if any, who controls such underwriter within the meaning of the Securities Act) from any loss, claim, damage or liability arising out of or based upon any untrue statement of a material fact contained in such
Registration Statement or any omissions to state therein a material fact required to be stated herein or necessary to make the statements therein not misleading, except for such statement or omission based on information furnished in writing by
(*NAME CONFIDENTIAL*) expressly for use in such Registration Statement; and (*NAME CONFIDENTIAL*) shall indemnify the Parent and Sub and each of its respective officers and directors who has signed such Registration Statement, each director and each
person, if any, who controls the Sub within the meaning of the Securities Act against any loss, claim, damage or liability arising from any such statement or omission which was made in reliance upon information furnished in writing to the Parent and
Sub expressly for use in such Registration Statement. 
 5.3 Representations and Warranties of Target and Controlling
Shareholder. Target and Controlling Shareholder jointly and severally represent and warrant to each of Parent and Sub, as of the date hereof and at the Effective Time, as follows: 
 (a) Target is an S-corporation duly formed, validly existing and in good standing under the laws of the State of (*STATE CONFIDENTIAL*). Controlling
Shareholder and Target have the requisite corporate power to execute and deliver this Agreement and to carry out the transactions contemplated hereby. If necessary, the Target is a duly qualified as a foreign corporation in good standing in each
jurisdiction in which the conduct of its business requires such qualification. 
 (b) The execution, delivery and performance by the
Controlling Shareholder and Target of this Agreement and the transactions contemplated hereby are within the powers of the Controlling Shareholder and Target and have been duly authorized by all necessary action. This Agreement constitutes a valid
and binding obligation of the Controlling Shareholder and Target, enforceable against the Controlling Shareholder and Target in accordance with its terms, subject to bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or other
similar laws of general application affecting the enforcement of creditors’ rights generally. 
 (c) All issued and outstanding shares
of Target have been duly authorized and issued, are fully paid and non-assessable, are free of preemptive rights, and will at the date of closing be owned of record and merged into Sub by the Controlling Shareholder in accordance with this
Agreement. The Target does not have any outstanding options, warrants or similar rights to acquire, or any securities convertible into or exchangeable for, any of its shares that have not been disclosed on Schedule 5.3(c). Upon consummation of the
transactions contemplated herein, the Sub will own all the interest in Target. Target shall cooperate with Parent and Sub as to the filing of the application for the License from the City of (*CITY CONFIDENTIAL*) pursuant to (*CITY CONFIDENTIAL*)
City Code, Section (*CODE CONFIDENTIAL), and all other applications necessary for Sub to operate the business of Target in the same manner and with the same rights as Target prior to the merger. 
  

 13 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 (d) There are no subsidiaries of Target. 
 (e) Neither the execution, delivery and performance by the Target and Controlling Shareholder of this Agreement, nor the consummation by the Target and
Controlling Shareholder of the transactions contemplated hereby, will (a) violate, conflict with, or result in a breach of, any provision of the charter or bylaws of the Target or (b) result in a default (or give rise to any right of
termination, cancellation or acceleration) under, any of the terms, conditions or provisions of any note, bond, mortgage, indenture, license, franchise, permit, lease, agreement or other instrument or obligation to which the Target is a party, or by
which its properties or assets may be bound, except for such violations, breaches or defaults which would not prevent or materially delay consummation of the transactions contemplated hereby. 
 (f) The Target will furnish to the Parent and Sub copies of the Target’s compiled balance sheets and related statements of income and cash flows
along with existing applicable tax documents from all governmental entities, if any, beginning October 1, 2004 through March 31, 2008, as set forth in Schedule 5.3(f), within fifteen (15) days of the execution of this Agreement. In
addition thereto, the Controlling Shareholder and Target shall cause to be furnished all compiled balance sheet and related statements of income from the execution of this Agreement through the Effective Time and Closing within 30 days following the
Closing. All of the above are herein referred to as the “Financial Statements.” The Financial Statements (i) are and will be complete and correct, (ii) do and will fairly present the financial condition of the Target as of the
dates thereof and the results of operations and cash flows of the Target for the periods covered thereby, and (iii) have been and will be prepared in accordance with generally accepted accounting methods consistently applied. There has been no
material adverse change in the operations or financial condition of the Target, taken as a whole, and no series of events have occurred that could reasonably be expected to have a Material Adverse Effect, as defined herein. All exceptions to the
foregoing, if any, are fully disclosed in Schedule 5.3(f) hereto. 
 (g) There are no liabilities, debts, obligations or claims against the
Target of any nature, absolute or contingent except (i) as and to the extent reflected or reserved against on the balance sheet of the Target as shown in the Financial Statements contained in Schedule 5.3(f), (ii) as specifically described
and identified as an exception to this paragraph in any of the schedules delivered to Parent or Sub pursuant to this Agreement or (iii) as incurred since the last date shown on the Financial Statements in the ordinary course of business
consistent with prior practice. All exceptions to the foregoing, if any, are fully disclosed in Schedule 5.3(g) hereto. 
 (h) With respect
to Taxes (as defined below): 
 (i) Target has filed, within the time and in the manner prescribed by law, all returns, declarations, reports,
estimates, information returns and statements (“Returns”) required to be filed under federal, state, local or any foreign laws by Target , and all such Returns are true, correct and complete in all material respects. 
 (ii) Except as set forth on Schedule 5.3(h)(i), Target has within the time and in the manner prescribed by law, paid (and until the Effective Time will,
within the time and in the manner prescribed by law, pay) all Taxes (as defined below) that are due and payable 
 (iii) Target has
established (and until the Effective Time will establish) on its respective books and records reserves (to be specifically designated as an increase to current liabilities) that are adequate for the payment of all Taxes not yet due and payable.

  

 14 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 (iv) There are no liens for Taxes upon the assets of Target except liens for Taxes not yet due.

 (v) Target has not filed (and will not file prior to the Effective Time) any consent agreement under Section 341 (f) of the Code
or agreed to have Section 341(f)(2) of the Code apply to any disposition of the subsection (f) asset (as such term is defined in Section 341(f)(4) of the Code) owned by Target. 
 (vi) Except as set forth in Schedule 5.3(h)(vi) (which shall set forth the type of return, date filed, and date of expiration of the statute of
limitations), (i) the statute of limitations for the assessment of federal income taxes has expired for all federal income tax returns of Target or such returns have been examined by the Internal Revenue Service for all periods through
September 30, 2004; (ii) the statute of limitations for the assessment of state, local and foreign income taxes has expired for all applicable Returns of Target or such Returns have been examined by the appropriate tax authorities for all
periods through September 30, 2004; and (iii) no deficiency for any Taxes has been proposed, asserted or assessed against Target which has not been resolved and paid in full. 
 (vii) There are no outstanding waivers or comparable consents regarding the application of the statute of limitations with respect to any Taxes or
Returns that have been given by Target. 
 (viii) Except as set forth on Schedule 5.3(h)(viii) (which shall set forth the nature of the
proceeding, the type of return, the deficiencies proposed or assessed and the amount thereof, and the taxable year in question), no federal, state, local or foreign audits or other administrative proceedings or court proceedings are presently
pending with regard to any Taxes or Returns. 
 (ix) Target is not a party to any tax-sharing or allocation agreement, nor does Target owe
any amount under any tax-sharing or allocation agreement. 
 (x) No amounts payable under the Plans (as defined in Section 5.3(m)) will
fail to be deductible for federal income tax purposes by virtue of Section 280G of the Code. 
 (xi) Target has complied (and until the
Effective Time will comply) in all respects with all applicable laws, rules and regulations relating to the payment and withholding of Taxes (including, without limitation, withholding of Taxes pursuant to Sections 1441 or 1442 of the Code or
similar provisions under any foreign laws) and have, within the time and in the manner prescribed by law, withheld from employee wages and paid over to the proper governmental authorities all amounts required to be so withheld and paid over under
all applicable laws. 
 (xii) Target has been a member of an “affiliated group” within the meaning of Section 1502 of the Code
and owes no taxes as a result of being said member, except as disclosed on Schedule 5.3(h)(xii). 
 (xiii) For purposes of this Agreement,
“Taxes” shall mean all taxes, charges, fees, levies or other assessments of whatever kind or nature, including, without limitation, all net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits,
license, withholding, payroll, employment, excise, estimated, severance, stamp, occupancy or property taxes, customs duties, fees, assessments or charges of any kind whatsoever (together with any interest and any penalties, additions to tax or
additional amounts) imposed by any taxing authority (domestic or foreign) upon or payable by Target or any subsidiary. 
 (i) The Target has
not, except as specifically disclosed on Schedule 5.3(i) attached hereto: 
 (i) transferred, assigned or conveyed any of its assets or
business or entered into any transaction or incurred any liability or obligation, other than in the ordinary course of its business and consistent with past practice; 
  

 15 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 (ii) suffered any adverse change in its business, operations, or financial condition of the business
of the Target or become aware of any event which may result in any such adverse change; 
 (iii) written off as uncollectible any notes or
accounts receivable or any portion thereof, other than in the ordinary course of business; 
 (iv) suffered any destruction, damage or loss
to property (casualty or other), whether or not covered by insurance; 
 (v) suffered, permitted or incurred the imposition of any lien,
charge, encumbrance (which as used herein includes, without limitation, any mortgage, deed of trust, conveyance to secure debt or security interest) or claim upon any of its assets, except for any current year lien with respect to personal taxes not
yet past due; 
 (vi) committed, suffered, permitted or incurred any default in any material liability or obligation; 
 (vii) made or agreed to any material adverse change in the terms of any contract or instrument to which it is a party; 
 (viii) waived, canceled, sold or otherwise disposed of, for less than the face amount thereof, any material claim or right it has against others;

 (ix) (a) disposed of or permitted to lapse, or otherwise failed to preserve then existing exclusive rights, if any, of the Target to
use any (i) patent, trademark, trademark registration, logo, assumed name, trade name, copyright or copyright registration, or (ii) any patent, trademark, trade name or copyright application, (b) disposed of or permitted to lapse any
license, permit or other form of authorization, or any trade name, or (c) disposed of or disclosed to any Person any trade secret, formula or process; 
 (x) made any change in any method of accounting or accounting practice; 
 (xi) declared, promised or made
any distribution or other payment to the Controlling Shareholder (other than compensation payable in the ordinary course to employees of the Target consistent with past practice), or issued any additional Shares or rights, options or calls with
respect to its Shares, or redeemed, purchased or otherwise acquired any of its Shares, or made any change whatsoever in its capital structure; 
 (xii) increased or changed, or agreed to increase or change, its obligation for any payment for, any contribution or other amount to, or with respect to, any employee benefit plan, or paid any bonus to, or granted any increase in the
compensation of, its directors, officers, agents or employees, or made any increase in the pension, retirement or other benefits of its directors, officers, agents or other employees; 
 (xiii) paid, loaned or advanced any amount to or in respect of, or sold, transferred or leased any properties or assets (whether real, personal, mixed,
tangible or intangible) to, or entered into any agreement, arrangement or transaction with, the Controlling Shareholder, any of the officers or directors of the Target, or any affiliate or associate of any of them, or any business or entity in which
the Controlling Shareholder or the Target or any affiliate or associate of any of them has any direct or indirect interest, except for compensation to the officers and employees of the Target or the Controlling Shareholder; 
  

 16 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 (xiv) committed, suffered, permitted or incurred any transaction or event which would increase its
tax liability for any prior taxable year; 
 (xv) entered into any lease of real property or material lease of personal property;

 (xvi) incurred any other liability or obligation or entered into any transaction other than in the ordinary course of business;

 (xvii) terminated or amended or suffered the termination or amendment of, or failed to perform in all material respects all of its
obligations or suffered or permitted any default to exist under any contract, lease, agreement or license; 
 (xviii) received any notices
that any supplier or customer has taken or contemplates any steps which could materially and adversely disrupt the business relationship of the Business with said supplier or customer; or 
 (xviv) agreed, whether in writing or otherwise, to take any action described in this Section 5.3. 
 (j) Except as listed or described on Schedule 5.3(j) hereto, as of the date hereof, the Target is not a party to or bound by any written or oral leases,
agreements, instruments, or other contracts or legally binding contractual commitments (“Contracts”) that are of a type described below (collectively, the “Material Contracts”): 
 (i) any collective bargaining arrangement with any labor union; 
 (ii) any Contract, singly or in the aggregate, for capital expenditures or the acquisition or construction of fixed assets in excess of
$2500.00; 
 (iii) any Contract, singly or in the aggregate, for the purchase or sale of inventory, materials, supplies,
merchandise, machinery, equipment, parts or other property, assets, or services requiring aggregate future payments in excess of $2500.00 (other than standard inventory purchase orders executed in the ordinary course of business); 
 (iv) any Contract relating to the borrowing of money or the guaranty of another person’s borrowing of money; 
 (v) any Contract granting any person a lien on all or any part of assets; 
 (vi) any Contract granting to any person a first refusal, first offer or similar preferential right to purchase or acquire any of its
assets; 
 (vii) any Contract under which the Target is (A) a lessee or sublessee of any machinery, equipment, vehicle
(including fleet equipment) or other tangible personal property, or (B) a lessor of any property, in either case having an original value in excess of $2500.00; 
 (viii) any Contract limiting, restricting or prohibiting it from conducting business anywhere in the United States or elsewhere in the
world or any Contract limiting the freedom of the Target to engage in any line of business or to compete with any other Person; 
 (ix) any joint venture or partnership Contract; 
  

 17 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 (x) Contracts, singly or in the aggregate, requiring future payments of $2500.00 or
more that require the consent of the other party thereto in connection with the transactions contemplated hereby; and 
 (xi)
any material employment Contract with any employee. 
 (xii) Any contract, oral or written, which is a part of the
Target’s ongoing business. 
 (k) The Controlling Shareholder has made available to the Parent and Sub a true and complete copy of each
written Material Contract, including all amendments or other modifications thereto. Except as set forth on Schedule 5.3(k) hereto, each Material Contract is a valid and binding obligation of each party thereto, enforceable in accordance with its
terms, subject only to bankruptcy, reorganization, receivership and other laws affecting creditors’ rights generally. Except as set forth on Schedule 5.3(k) hereto, the Target has performed all obligations required to be performed by it under
the Material Contracts and the Business is not in breach or default thereunder. 
 (l) Target is not in violation of any Law. Target has all
permits, approvals, licenses and franchises from governmental authorities required to conduct their business as now being conducted (collectively “Permits”), and is in compliance with all such Permits. Target shall assist Parent and Sub
with obtaining the necessary Licenses from the City of (*CITY CONFIDENTIAL*) pursuant to (*CITY CONFIDENTIAL*) City Code, Section (*CODE CONFIDENTIAL), giving Parent and Sub the right to operate the business of Target in the same manner and
with the same rights as Target prior to the merger. 
 (m) With respect to the employees of Target and each subsidiary: Target shall provide:

 (i) Schedule 5.3(m)(i) listing each compensation arrangement or benefit plan; 
 (ii) Schedule 5.3(m)(ii) listing each employee pension benefit plan; 
 (iii) Schedule 5.3(m)(iii) listing each employee welfare benefit plan. 
 Further, except as listed on Schedule 5.3(m), Target has no accumulated funding deficiencies, no material liability, no plan or commitment to create additional plans, no health benefits to employees after retirement ,
and has complied with (*CODE CONFIDENTIAL), each plan is “qualified”, and each plan is operated under the applicable laws. Target, except as shown on Schedule 5.3(l) hereto, within the last two years, not experienced any strike, picketing,
boycott, work stoppage or slowdown or other labor dispute, nor is any such event or any organizing effort threatened against it, and there is no pending charge or complaint of unfair labor practice, employment discrimination or similar matters
against the Target relating to the employment of labor. 
 (n) Except as set forth in Schedule 5.3(n), there are no claims, actions, suits,
approvals, investigations, informal objections, complaints or proceedings pending against or affecting Target before any court, arbiters or administrative, governmental or regulatory authority or body, or any of the Business or assets thereof,
subject to any order, judgment, writ, injunction or decree. There are no claims, actions, suits, approvals, investigations, informal objections, complaints or proceedings pending against the Target before any court arbiters, or administrative,
governmental or regulatory authority or body, nor is the Target subject to any order, judgment, writ, injunction or decree, for matters which will not prevent, materially delay or materially burden the transactions contemplated hereby. 

(o) Except as set forth in Schedule 5.3(o), Target has not disposed of or permitted to lapse, or otherwise failed to preserve then existing exclusive
rights, if any, of the Target to use any (i) patent, trademark, trademark registration, logo, assumed name, trade name, copyright or copyright registration, or (ii) any patent, trademark, trade name or copyright application,
(b) disposed of or permitted to lapse any license, permit or other form of authorization, or any trade name, or (c) disposed of or disclosed to any person any trade secret, formula or process. 
  

 18 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 (p) Target has in full force business interruption insurance covering risk of loss as a result of
cessation of any substantial part of the business conducted by the Target for such periods as are customary for companies of established reputation engaged in the same or similar business and similarly situated. 
 (q) The inventory of Target is saleable (except as limited by the (*STATE CONFIDENTIAL*) Alcohol Beverage Code). 
 (r) The Target currently uses two (2) ATM machines and a processing service from an outside provider, and that said agreement with such outside
provider shall be terminated at or prior to the Effective Time and Closing. 
 ARTICLE VI 
 COVENANTS 
 6.1 Conduct of Business
of Target Pending the Merger. Target and Controlling Shareholder agree that from the date hereof and prior to the Effective Time and Closing or earlier termination of this Agreement: 
 (a) Target shall provide access to all books, records and accounts, liability policies, financial statements, audited or unaudited financial records, true
and accurate copies of tax returns and other necessary documents held in the ordinary course of business for the Target. 
 (b) Except as
otherwise expressly provided in this Agreement, prior to the Effective Time, the Target will not and Controlling Shareholder will not permit: 
 (i) Target to, without the prior written consent of the Parent and Sub, sell, pledge, dispose of or encumber its assets, except for sales of inventory and sales of obsolete assets and assets concurrently replaced with similar assets, in
each case in the ordinary course of its business. 
 (ii) Target to declare or make any dividends or other distributions on the common
stock, or repurchase or otherwise reacquire for value any shares of common stock. 
 (iii) Target to issue any Shares of capital stock, or
any warrants, options or other rights to purchase or acquire any capital stock. 
 (iv) Target to incur any indebtedness for borrowed money
other than borrowings for working capital purposes under existing credit facilities in the ordinary course of business. 
 (v) Target to
amend any tax return, change any method of tax accounting, make any elections that have any effect on any tax return, file for or make any refund claims relating to any tax or any tax return or settle any issues arising in any tax audit or contest.

 (vi) Target to, other than in the ordinary course of business, enter into any Material Contract (including without limitation, any
arrangement with any governmental body) or any amendment, cancellation or termination of any Material Contract, including without limitation any Contract with any governmental body or agency, or take any action impairing its 

  

 19 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 
rights under any Material Contract or take, or fail to take, any action that constitutes a material breach or default under any Material Contract;

 (vii) Target to amend or propose to amend the charter or bylaws of any of the Target. 
 (viii) permit Target to agree to do any of the foregoing. 
 (ix) use its best efforts to retain Target’s managers who have been employed at least sixty (60) days who will be identified in Schedule 6.1(b)(ix) during Due Diligence, but in the event it is unable to do
so, agree that they will not hire any of said managers prior to six (6) months after the Closing. This specifically excludes (*NAMES CONFIDENTIAL*), who are free to work at any business at any time. 
 (c) Except as contemplated by this Agreement or otherwise consented to in writing by all parties hereto, during the period from the date of this
Agreement to the Effective Time, the Target shall, and the Controlling Shareholder shall cause the Target to, conduct their business in the ordinary course of business consistent with past practice, all as may be required to carry on the business in
the ordinary course of the Target consistent wit past practice, and Target will not intentionally take any actions that could reasonably be expected to have a Material Adverse Effect. 
 6.2. Intentionally left blank. 
 6.3 Financial Statements. During the period following execution of this Agreement through the Effective Time, Target must furnish regular financial statements to Parent. 
 6.4 Approval of Shareholders. Target shall (a) cause a meeting of its shareholders to be duly called and held in accordance
with the laws of the State of (*STATE CONFIDENTIAL*), applicable federal and state securities laws and Target’s Articles of Incorporation and By-Laws as soon as reasonably practicable for the purpose of voting on the adoption and approval of
this Agreement, the Agreement of Merger, and the Merger (the “Proposal”), (b) recommend to its shareholders approval of the Proposal (except to the extent that the board of directors of Target determines, after receiving the written
advice of counsel, that such act is not permitted by such board of directors in the discharge of their fiduciary duties to Target), (c) use its best efforts to obtain the necessary approval of its shareholders, (d) intentionally omitted,
and (e) in cooperation with Parent mail to shareholders a transmittal letter in form and substance reasonably satisfactory to Parent to be used by such shareholders in forwarding their certificates for surrender and exchange. Except with the
prior written consent of Parent, neither Target nor Controlling Shareholder shall distribute any materials to Target’s Shareholders in connection with the Proposal other than the Proxy Statement. 
 6.5 Securities Law Compliance. (a) Parent shall promptly prepare and file a Registration Statement on Form S-4 under the
Securities Act, covering the issuance of Parent Common Stock into which Target Common Stock outstanding at the Effective Time of the Merger is to be converted. 
 (b) Parent will take any action required to be taken under applicable state securities laws and Parent will also take action to secure all necessary exemptions or clearances under all state securities laws applicable
to (i) the Merger, (ii) the issuance of Parent Common Stock pursuant thereto. 
 (c) Parent will promptly deliver to Target copies
of any filings made by Parent or Sub pursuant to this Section 6.5., if same is required 
 6.6 Third Party Consents.
Each party to this Agreement shall use its best efforts to obtain, as soon as reasonably practicable, all permits, authorizations, consents, waivers and approvals from third parties or 

  

 20 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 
governmental authorities necessary to consummate this Agreement and the Agreement of Merger (as shown on Schedule 6.6 hereto as shown in Section 4.7
Special Permits) and the transactions contemplated hereby or thereby, including, without limitation, any permits, authorizations, consents, waivers and approvals required in connection with the Merger. 
 6.7 Exchange Listing. The shares of common stock to be issued will be shares of the Parent listed on NASDAQ and have been registered
at the time of the Closing Date, or will be registered in an S-3 registration statement filed with the SEC by the Parent at its expense. 
 6.8 Personnel of Parent and Sub. Upon execution hereof, Controlling Shareholder and Target shall allow an individual designated by Parent and Sub to immediately be placed into the operating facility of Target for an
inspection of the day-to-day operation of the business of Target, including but not limited to accountings, business operations, cash management, and other day-to-day material aspects of Target’s business. Controlling Shareholder and Target
hereby covenant that the individual so designated by Parent and Sub shall have full and open opportunity to observe every aspect of the operations of Target’s business, and shall cooperate with that individual in providing reasonably requested
information, documents, personnel, and other vital elements of the day-to-day operations of Target’s business. 
 6.9
Publicity. The Controlling Shareholder and Target hereby covenant that they shall not issue any press release or otherwise making any public statement with respect to this Agreement, or the transactions contemplated hereby.
Controlling Shareholder and Target covenant that they shall not object, and accept certain mandated regulated announcements which must be made, and covenant that Parent and Sub shall be allowed to make all necessary press releases, statements, or
other such comments as required by law, rule or regulation without consultation and restriction. 
 ARTICLE VII 
 DUE DILIGENCE 
 7.1 Due
Diligence. Upon execution hereof, Controlling Shareholder and Target shall within fifteen (15) business days, as set forth in Section 5.3(f), produce for inspection and review the business records of Target beginning as of
October 1, 2004 through March 31, 2008 for the inspection by Parent and Sub, along with a copy of any items to be included on any or all of the schedules which are a part of this Agreement. Upon receipt of the Financial Statements and
completion of the schedules hereto, Parent and Sub shall have thirty (30) days from receipt thereof (or a lesser amount of time determined in the sole and absolute discretion of Parent and Sub) for inspection of these records, to determine the
economic condition, and viability of the Target, laws, rules, regulations, applicable to the Target’s assets, books, records, documents, contracts, and agreements related to the Target. 
 7.2. Termination. Should Parent and Sub not be satisfied with the results of the inspection of the Financial Statements, and/or
information contained on completed schedules hereto, Parent and Sub shall have the right to terminate this Agreement for any reason or no reason at all based on their sole and absolute discretion. 
 7.3 Covenant of Cooperation. Controlling Shareholder and Target or its employees and agents, shall fully and accurately cooperate
with Parent and Sub in all aspects of their inquiry during this due diligence phase. 
 7.4 Confidentiality. If the Plan
does not become effective, the parties shall, upon termination or abandonment of the Plan or its negotiations remain bound as follows: 
  

 21 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 NON-DISCLOSURE CONFIDENTIALITY AGREEMENT 
 TO PROTECT RELEASE OF CONFIDENTIAL 
 AND PROPRIETARY INFORMATION 
 a. During the course of the negotiations, discussions and investigations related to the acquisition by “Parent” and “Sub” of (*NAME
CONFIDENTIAL*) stock in (*NAME CONFIDENTIAL*). and the underlying investigation of (*NAME CONFIDENTIAL*), and indirectly its wholly owned subsidiaries related to the possible acquisition, any confidential or proprietary information of (*NAME
CONFIDENTIAL*),(*NAME CONFIDENTIAL*) and its subsidiaries which may be reviewed by “Parent” and “Sub” and personal information about (*NAME CONFIDENTIAL*) shall not be disclosed at any time to any third parties (hereinafter
“confidential or proprietary information”). “Parent” and “Sub” hereby agrees not to disclose to any third party any confidential or proprietary information of (*NAME CONFIDENTIAL*), individually, (*NAME CONFIDENTIAL*)
and any subsidiary of (*NAME CONFIDENTIAL*) except as may be specifically authorized in writing by (*NAME CONFIDENTIAL*), individually and as president of (*NAME CONFIDENTIAL*) or as president of any particular subsidiary. 
 b. During the course of the negotiations, discussions and investigations related to the acquisition by “Parent” and “Sub” of (*NAME
CONFIDENTIAL*) stock in (*NAME CONFIDENTIAL*) and underlying investigation of “Parent” and “Sub” and indirectly its wholly owned subsidiaries related to the possible acquisition, any confidential or proprietary information of
“Parent” and “Sub” and its subsidiaries which may be reviewed by (*NAME CONFIDENTIAL*) and (*NAME CONFIDENTIAL*) and personal information about “Parent” and “Sub” shall not be disclosed at any time to any
third parties (hereinafter “confidential or proprietary information”). (*NAME CONFIDENTIAL*) and (*NAME CONFIDENTIAL*) hereby agree not to disclose to any third party any confidential or proprietary information of “Parent” and
“Sub”. and any subsidiary of “Parent” and “Sub” except as may be specifically authorized in writing by “Parent” and “Sub” or any particular subsidiary. 
 c. The term “confidential or proprietary information” in this Agreement includes but is not limited to all of the following: customer lists,
product pricing, business plans, license information, financial data, information on any and all tangential legal matters, salaries, employee information (employer benefit information, practices and procedural manuals, management techniques,
contracts or agreements, provisions related to insurance, insurance claims, claims, assets, all forms or information provided to any governmental entity or agency, licensing, valuation of assets, audits, internal audits, tax returns, profit and loss
statements or otherwise as designated by (*NAME CONFIDENTIAL*), (*NAME CONFIDENTIAL*) or “Parent” and “Sub”. 
 d. Each
party agrees that it shall do all things necessary to prevent any of its employees, representatives, or agents from disclosing any sensitive information to such third parties, including without limitation requiring each employee representative or
agent to sign a copy of this Agreement before being authorized by said party to have access to such information. 
 e. The term
““Parent” and “Sub” as used herein, shall include, but not be limited to, any employee, agent or representative or those acting by or through them including but not limited to third party independent contractors such as
attorneys, accountants, business appraisers, financial advisors or otherwise. 
 f. The term “(*NAME CONFIDENTIAL*),” as used
herein, shall include, but not be limited to, any employee, agent or representative or those acting by or through them including but not limited to 

  

 22 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 
third party independent contractors such as attorneys, accountants, business appraisers, financial advisors or otherwise. 
 g. The term “(*NAME CONFIDENTIAL*),” as used herein, shall include, but not be limited to, any employee, agent or representative or those
acting by or through them including but not limited to third party independent contractors such as attorneys, accountants, business appraisers, financial advisors or otherwise. 
 h. “Parent” and “Sub” agree not to use any confidential or proprietary information disclosed by them except for the purposes of
determining whether to acquire stock of (*NAME CONFIDENTIAL*) in (*NAME CONFIDENTIAL*). (*NAME CONFIDENTIAL*) and (*NAME CONFIDENTIAL*) agree not to use any confidential information obtained by them except to determine whether to be acquired or
allow stock to be acquired by “Parent” and “Sub”. 
 i. Upon the termination or expiration of all discussions between
“Parent” and “Sub”, (*NAME CONFIDENTIAL*) and (*NAME CONFIDENTIAL*), “Parent” and “Sub” shall surrender to (*NAME CONFIDENTIAL*) and to (*NAME CONFIDENTIAL*), any and all of its wholly owned subsidiaries all
originals and all copies of such confidential and proprietary information in “Parent” and “Sub’s possession or any other information in its possession related to (*NAME CONFIDENTIAL*), (*NAME CONFIDENTIAL*), or any of (*NAME
CONFIDENTIAL*) wholly owned subsidiaries. 
 j. Upon the termination or expiration of all discussions between “Parent” and
“Sub”, (*NAME CONFIDENTIAL*) and (*NAME CONFIDENTIAL*), (*NAME CONFIDENTIAL*) and (*NAME CONFIDENTIAL*) shall surrender to “Parent” and “Sub” any and all of its wholly owned subsidiaries all originals and all copies of
such confidential and proprietary information in (*NAME CONFIDENTIAL*) possession or any other information in its possession related to “Parent” and “Sub” or any of “Parent” and “Sub’s wholly owned
subsidiaries. 
 k. “Parent” and “Sub” agree that the confidential and proprietary information includes any information
that is already known to them, learned in preliminary negotiations which shall also be protected by the terms of this Agreement. 
 l. (*NAME
CONFIDENTIAL*) and (*NAME CONFIDENTIAL*) agree that the confidential and proprietary information includes any information that is already known to them, learned in preliminary negotiations which shall also be protected by the terms of this
Agreement. 
 m. “Parent” and “Sub” may release any confidential or proprietary information if consented to by (*NAME
CONFIDENTIAL*), or (*NAME CONFIDENTIAL*), if consented to by written authorization executed by (*NAME CONFIDENTIAL*) (for his personal information) or if related to a business, the president of that particular business, i.e., (*NAME CONFIDENTIAL*),
by its president and any subsidiary of (*NAME CONFIDENTIAL*), by its subsidiaries. 
 n. (*NAME CONFIDENTIAL*) or (*NAME CONFIDENTIAL*), may
release any confidential or proprietary information if consented to by “Parent” and “Sub” if consented to by written authorization or if related to a business, the president of that particular business, i.e., “Parent”
and “Sub” by its president and any subsidiary of “Parent” and “Sub” by its subsidiaries. 
 o. If suit is
brought to enforce this Agreement by (*NAME CONFIDENTIAL*), (*NAME CONFIDENTIAL*) or any of its subsidiaries they are entitled to the equitable relief, to recover all actual damages from the disclosure that has already taken place prior to the
injunctive relief and all attorneys fees and court costs. 
  

 23 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 p. Violation of this Agreement is enforceable by specific performance including injunctive relief and
mandatory injunctive relief. If suit is brought to enforce this Agreement by “Parent” and “Sub”. or any of its subsidiaries they are entitled to the equitable relief, to recover all actual damages from the disclosure that has
already taken place prior to the injunctive relief and all attorneys fees and court costs. 
 The confidentiality part of this Agreement is to be construed
under the laws of the State of (*STATE CONFIDENTIAL*) and is performable in the State of (*STATE CONFIDENTIAL*). Venue for any legal action hereunder lies in (*COUNTY CONFIDENTIAL*) County, (*STATE CONFIDENTIAL*). 
 ARTICLE VIII 
 CONDITIONS TO CLOSING 

 8.1 Conditions to Each Party’s Obligation to Effect the Merger. The respective obligations of each party to
effect the Merger shall be subject to the fulfillment of all of the following conditions precedent at or prior to the Effective Time and Closing: 
 (a) The merger contemplated herein as evidenced by the Agreement of Merger executed on even date herewith has been approved by the Target shareholders. 
 (b) The shares of common stock of the Parent are listed on NASDAQ. 
 (c) Intentionally omitted. 

(d) In the event it is applicable, the Parent and Sub shall have complied with the Registration Statement and, if necessary due to the waiting period
therefor, the Closing and Effective Time shall be moved until ten (10) days after said Registration Statement shall have become effective. 
 (e) There is no injunction or other or decree by any Federal, state or foreign court which prevents the consummation of the merger contemplated herein. 
 (f) There is no statute or regulation enacted which would prevent consummation of the merger contemplated herein. 
 (g) All governmental consents and approvals required for the merger have been obtained, including obtaining the Sub’s License from the City of (*CITY CONFIDENTIAL*) pursuant to (*CITY CONFIDENTIAL*) City Code, Section (*SECTION NUMBER
CONFIDENTIAL*) and the (*STATE CONFIDENTIAL*) Alcoholic Beverage Commission Mixed Beverage Permit with Late Hours for the rights granted by (*NAME CONFIDENTIAL*) to sell alcoholic beverages under the same terms and conditions as the Target, and Sub
having the right to operate the business of Target in the same manner and with the same rights as Target prior to the merger. It is the intention of the parties hereto to effectuate simultaneous grantings of Sub’s permits as stated above
without the risk of Target losing its rights and permits should this merger fail to close because of Sub’s failure to obtain the special Permits or rights as set forth in Section 4.7. 
 (h) This Agreement, the Agreement of Merger, the Covenants Not to Compete, the Ground Lease and the Sales Agreement shall be contingent upon execution of
and simultaneous Closing of the other by all parties. 
 (i) All governmental consents and resolutions of the special permits, as provided
for in Section 4.7 have been complied with and the SOB license is issued to the Sub for (*ADDRESS CONFIDENTIAL*). 
 8.2
Conditions to Obligations of Target to Effect the Merger. The obligation of Target to effect the Merger 

  

 24 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 
is subject to fulfillment of all of the following conditions precedent at or prior to the Effective Time and Closing: 
 (a) All representations and warranties made by Parent and Sub are true. 
 (b) All obligations of Parent and Sub under this Agreement and the Agreement of Merger have been performed. 
 (c) Target shall have received the certificate of the president and/or manager of Parent and Sub certifying that the conditions Sections 8.2(a) and 8.2(b) have been fulfilled. 
 (d) Intentionally omitted. 
 (e)
Intentionally omitted. 
 (f) There have been no Material Adverse Changes, as defined in Section 9.2(b) hereof. 
 (g) This Agreement, the Agreement of Merger, the Covenants Not to Compete, the Ground Lease and the Sales Agreement shall be contingent upon execution of
and simultaneous Closing of the other by all parties. 
 (h) Compliance with all representations related to securities have been fulfilled.

 8.3 Conditions to Obligations of Parent and Sub to Effect the Merger. The obligations of Parent and Sub to effect the
Merger are subject to the fulfillment of all of the following conditions precedent at or prior to the Effective Time and Closing: 
 (a) All
representations and warranties made by Target and Controlling Shareholder are true. 
 (b) All obligations of Target and Controlling
Shareholder under this Agreement and the Agreement of Merger have been performed. 
 (c) Parent and Sub shall have received a certificate of
the president of Target certifying that the conditions contained in Section 8.3(a) and 8.3(b) have been fulfilled. 
 (d) Intentionally
omitted. 
 (e) All consents and approvals necessary for the Merger shall have been obtained. 
 (f) This Agreement, the Agreement of Merger, the Covenants Not to Compete, the Ground Lease and the Sales Agreement shall be contingent upon execution of
and simultaneous Closing of the other by all parties. 
 ARTICLE IX 
 INDEMNIFICATION 
 9.1 General Indemnification
Covenants. Subject to the provisions of Sections 9.3 and 9.4, Controlling Shareholder shall indemnify, save and keep Parent and its affiliates, successors and permitted assigns (including Target and the
Surviving Company) (the “Parent Indemnitees”), harmless against and from all liability, demands, claims, actions or causes of action, assessments, losses, fines, penalties, costs, damages and expenses, including reasonable attorneys’
fees, disbursements and expenses (collectively, “Damages”), sustained or incurred by any of the Parent Indemnitees as a result of, arising out of or by virtue of any misrepresentation, breach of any warranty or representation, or
non-fulfillment of any agreement or covenant on the part of Target or Controlling Shareholder, whether contained in this Agreement or the Agreement of Merger or any schedule hereto or thereto or any written statement or certificate furnished or to
be furnished to Parent or Sub pursuant hereto or in any closing document delivered by Target or Controlling Shareholder to Parent or Sub in connection herewith. In the event any claim or cause of action is made pursuant to this paragraph, unless the
parties agree otherwise in writing, such claim or cause of action shall first be arbitrated pursuant to the provisions of Section 11.9 hereof. 
  

 25 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 9.2 Tax Indemnity. (a) Controlling Shareholder hereby agrees to pay,
indemnify, defend and hold Parent and Sub harmless from and against any and all Taxes of Target and its subsidiaries with respect to any period (or any portion thereof) up to and including the Effective Time, except for Taxes of Target and its
subsidiaries which are reflected as current liabilities for Taxes that exist as of the Effective Time (“Current Tax Liabilities”) on the Closing Balance Sheet, together with all reasonable legal fees, disbursements and expenses incurred by
Parent and Sub in connection therewith. 
 (b) Parent shall prepare and file any Return of Target and its subsidiaries which is required to
be filed after the Effective Time and which relates to any period (or portion thereof) up to and including the Effective Time, and Parent shall, within forty five (45) days prior to the due date of any such Return, deliver a draft copy to
Controlling Shareholder. Within thirty (30) days of the receipt of any such Return, Controlling Shareholder may reasonably request changes, in which event Parent and Controlling Shareholder shall attempt to agree on a mutually acceptable
resolution of the issues in dispute. If a resolution is reached, such Return shall be filed in accordance therewith. If a resolution is not reached, then at the expense of Parent and Controlling Shareholder (such expense to be shared equally), such
Return shall be submitted to a firm of independent certified public accountants selected by Parent and reasonably acceptable to Controlling Shareholder, which shall be directed to resolve the issues in dispute and prepare the Return for filing. As
soon as is practicable after notice from Parent to Controlling Shareholder at any time prior to the date any payment for Taxes attributable to any such Return is due, provided such Return is prepared for filing in accordance with the foregoing, an
amount equal to the excess, if any, of (i) Taxes that are due with respect to any taxable period ending on or before the Effective Time, or taxes that would have been due with respect to a taxable period beginning before and ending after the
Effective Time if such period had ended on the Effective Time over (ii) the amount of such Taxes of Target and its subsidiaries with respect to such taxable period which are reflected as Current Tax Liabilities on the Closing Balance Sheet
shall be paid by Controlling Shareholder to Parent by way of a release to Parent of shares of Parent Common Stock in accordance with those terms of the Escrow Agreement applicable to this Section 9.2(b), and any balance of such amount still
owing under this Section 9.2(b) after the release of such shares of Parent Common Stock shall be paid by Controlling Shareholder to Parent by wire transfer of immediately available funds within three business days after the release of such
shares of Parent Common Stock. 
 (c) The indemnity provided for in this Section 8.2 shall be independent of any other indemnity
provision hereof and, anything in this Agreement to the contrary notwithstanding, shall survive until the expiration of the applicable statutes of limitation for the Taxes referred to herein, and any Taxes subject to the indemnification for Taxes
set forth in this Section 9.2 shall not be subject to the provisions of Sections 9.1 or 9.4 hereof. Notwithstanding anything in this Agreement to the contrary, Controlling Shareholder will not be obligated to indemnify Parent and Sub under any
provision of this Agreement with respect to Taxes or other liabilities that arise as a direct result of a failure of the Merger to qualify as reorganization within the meaning of Section 368(a) of the Code. 
 9.3 Limitations on Indemnification. (a) The obligations of Controlling Shareholder pursuant to Sections 9.1 and 9.2 are subject
to the following limitations: 
 (a) Intentionally omitted. 
 (b) Controlling Shareholder shall not have any indemnification obligation with respect to the first $10,000.00 of total liabilities incurred under Sections 9.1 and 9.2, unless the total aggregate liabilities of
Controlling Shareholder under Sections 9.1 and 9.2 equal or exceed such amount, which amount shall be defined as a Material Adverse Change, as that term is used herein, in which case the indemnification obligations of Controlling Shareholder will
include all liabilities in excess of $10,000.00 incurred under Sections 9.1 and 9.2. 
 9.4 Conditions of Indemnification Pursuant
to Section 9.1. (a) Promptly following the receipt by a Parent Indemnitee of notice of a demand, claim, action, assessment or proceeding made or brought by a third party, including a governmental agency (a “Third Party
Claim”), the Parent Indemnitee receiving the notice of the Third Party Claim (i) shall notify Controlling Shareholder of its existence, setting forth the facts and circumstances of which such Parent Indemnitee has received notice, and
(ii) if the Parent Indemnitee giving such notice is a person entitled to indemnification under this Article IX (an “Indemnified Party”), specifying the basis hereunder upon which the Indemnified Party’s claim for indemnification
is asserted. 
  

 26 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 (b) The Indemnified Party shall, upon reasonable notice by Controlling Shareholder, tender the
defense of a Third Party Claim to Controlling Shareholder. If Controlling Shareholder accepts responsibility for the defense of a Third Party Claim, then Controlling Shareholder shall have the exclusive right to contest, defend and litigate the
Third Party Claim and shall have the exclusive right, in his discretion exercised in good faith and upon the advice of counsel, to settle any such matter, either before or after the initiation of litigation, at such time and upon such terms as he
deems fair and reasonable, provided that at least ten (10) days prior to any such settlement, he shall give written notice of his intention to settle to the Indemnified Party. The Indemnified Party shall have the right to be represented by
counsel at its own expense in any defense conducted by Controlling Shareholder. 
 (c) Notwithstanding the foregoing, in connection with any
settlement negotiated by Controlling Shareholder, no Indemnified Party shall be required to (x) enter into any settlement (A) that does not include the delivery by the claimant or plaintiff to the Indemnified Party of a release from all
liability in respect of such claim or litigation, (B) if the Indemnified Party shall, in writing to Controlling Shareholder within the ten (10) day period prior to such proposed settlement, disapprove of such settlement proposal and desire
to have Controlling Shareholder tender the defense of such matter back to the Indemnified Party, or (C) that requires an Indemnified Party to take any affirmative actions as a condition of such settlement, or (y) consent to the entry of
any judgment that does not include a full dismissal of the litigation or proceeding against the Indemnified Party with prejudice; provided, however, that should the Indemnified Party disapprove of a settlement proposal pursuant to Clause
(B) above, the Indemnified Party shall thereafter have all of the responsibility for defending, contesting and settling such Third Party Claim but shall not be entitled to indemnification by Controlling Shareholder to the extent that, upon
final resolution of such Third Party Claim, Controlling Shareholder’s liability to the Indemnified Party but for this proviso exceeds what Controlling Shareholder’s liability to the Indemnified Party would have been if Controlling
Shareholder were permitted to settle such Third Party Claim in the absence of the Indemnified Party exercising its right under clause (B) above. 
 (d) If, in accordance with the foregoing provisions of this Section 9.4, an Indemnified Party shall be entitled to indemnification against a Third Party Claim, and if Controlling Shareholder shall fail to accept
the defense of a Third Party Claim which has been tendered in accordance with this Section 9.4, the Indemnified Party shall have the right, without prejudice to its right of indemnification hereunder, in its discretion exercised in good faith
and upon the advice of counsel, to contest, defend and litigate such Third Party Claim, and may settle such Third Party Claim, either before or after the initiation of litigation, at such time and upon such terms as the Indemnified Party deems fair
and reasonable, provided that at least ten (10) days prior to any such settlement, written notice of its intention to settle is given to Controlling Shareholder. If, pursuant to this Section 9.4, the Indemnified Party so defends or settles
a Third Party Claim for which it is entitled to indemnification hereunder, as hereinabove provided, the Indemnified Party shall be reimbursed by Controlling Shareholder for the reasonable attorneys’ fees and other expenses of defending the
Third Party Claim which are incurred from time to time, forthwith following the presentation to Controlling Shareholder of itemized bills for said attorneys’ fees and other expenses. No failure by Controlling Shareholder to acknowledge in
writing his indemnification obligations under this Article IX shall relieve him of such obligations to the extent they exist. 
 9.5
Certain Tax and Other Matters. (a) If, in connection with the audit of any Return, a proposed adjustment is asserted in writing with respect to any Taxes of Target for which Controlling Shareholder is required to indemnify
Parent or Sub pursuant to Section 9.2(a) hereof, Parent shall notify Controlling Shareholder of such proposed adjustment within twenty (20) days after the receipt thereof. Upon notice to Parent within twenty (20) days after receipt of
the notice of such proposed adjustment from Parent, Controlling Shareholder may assume (at Controlling Shareholder’s own cost and expense) control of and contest such proposed adjustment. 
 (b) Alternatively, if Controlling Shareholder requests within twenty (20) days after receipt of notice of such proposed adjustment from Parent,
Parent or Sub, as the case may be, shall contest such proposed adjustment Controlling Shareholder shall be obligated to pay all reasonable out-of-pocket costs and expenses (including legal fees and expenses) which Parent or Sub may incur in so
contesting such proposed adjustment as such costs and expenses are incurred, and Parent shall have the full right to contest such proposed adjustment and shall be entitled to settle or agree to pay in full such proposed adjustment (in its sole
discretion) and thereafter pursue its rights under this Agreement. Controlling Shareholder shall pay to Parent all indemnity amounts in respect of any such proposed adjustment within thirty (30) days after written demand to Controlling
Shareholder 

  

 27 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 
therefor, or, if Controlling Shareholder has assumed control of the contest of such proposed adjustment as provided above (or has requested Parent or Sub to
contest such proposed adjustment within the time provided above), within thirty (30) days after such proposed adjustment is settled or a Final Determination has been made with respect to such proposed adjustment. 
 (c) For purposes of this Section 9.5, a “Final Determination” shall mean (i) the entry of a decision of a court of competent
jurisdiction at such time as an appeal may no longer be taken from such decision or (ii) the execution of a closing agreement or its equivalent between the particular taxpayer and the Internal Revenue Service, as provided in Section 7121
and Section 7122, respectively, of the Code, or a corresponding agreement between the particular taxpayer and the particular state or local taxing authority. The obligation of Controlling Shareholder to make any indemnity payment pursuant to
Section 9.2(a) shall be premised on the receipt by Controlling Shareholder from Parent or Sub of a written notice setting forth the relevant portion of any Final Determination. 
 9.6 Certain Information. Parent, Controlling Shareholder and Target agree to furnish or cause to be furnished to each other (at
reasonable times and at no charge) upon request as promptly as practicable such information (including access to books and records) pertinent to Target and assistance relating to Target as is reasonably necessary for the preparation, review and
audit of financial statements, the preparation, review, audit and filing of any Tax Return, the preparation for any audit or the prosecution or defense of any claim, suit or proceeding relating to any proposed adjustment or which may result in
Controlling Shareholder being liable under the indemnification provisions of this Article IX, provided, that access shall be limited to items pertaining solely to Target or its subsidiaries. Controlling Shareholder shall grant to Parent access to
all Tax Returns filed with respect to Target or its subsidiaries. 
 9.7 Release by Controlling Shareholder. Controlling
Shareholder hereby releases and discharges Parent and Sub and each of its officers and directors from, and agrees and covenants that in no event will Controlling Shareholder commence any litigation or other legal or administrative proceeding
against, Parent, Sub or any of their officers or directors, whether in law or equity, relating to any and all claims and demands, known and unknown, suspected and unsuspected, disclosed and undisclosed, for damages, actual or consequential, past,
present and future, arising out of or in any way connected with his ownership or alleged ownership of Target Common Stock prior to the Effective Time, other than claims or demands arising out of the transactions contemplated by this Agreement and
the Agreement of Merger. 
 ARTICLE X 
 TERMINATION, AMENDMENT AND WAIVER 
 10.1 Termination. This Agreement may be terminated at any time
prior to the Effective Time, whether before or after approval by the shareholders of Target: 
 (a) by mutual consent of Parent and Target; or

 (b) by either Parent or Target if (i) the Merger shall not have been consummated on or before May 1, 2008 (the “Termination
Date”), except as may be extended in accordance with Sections 8(c) and 8(d) hereof, or if by mutual agreement of the parties the Termination Date is extended to allow the parties additional time to perform the due diligence as set forth in
Article VII hereof, (ii) the requisite vote of the shareholders of Target to approve this Agreement, the Agreement of Merger and the transactions contemplated hereby and thereby shall not be obtained at the meetings, or any adjournments
thereof, called therefor, (iii) any governmental or regulatory body, the consent of which is a condition to the obligations of Parent, Sub and Target to consummate the transactions contemplated hereby or by the Agreement of Merger, shall have
determined not to grant its consent and all appeals of such determination shall have been taken and have been unsuccessful, including but not limited to obtaining the License from the City of (*CITY CONFIDENTIAL*) pursuant to (*CITY CONFIDENTIAL*)
City Code, Section (*SECTION NUMBER CONFIDENTIAL*) allowing Parent and Sub to have the right to operate the business of Target in the same manner and with the same rights as Target prior to the merger, or (iv) any court of competent
jurisdiction in the United States or any State shall have issued an order, judgment or decree (other than a temporary restraining order) restraining, enjoining or otherwise prohibiting the Merger or 

  

 28 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 
the granting of the License from the City of (*CITY CONFIDENTIAL*) and preventing the Parent and Sub from operating the business of Target in the same manner
and with the same rights as Target prior to the merger, and such order, judgment or decree or failure to issue said License from the City of (*CITY CONFIDENTIAL*) shall have become final and nonappealable. 
 10.2 Effect of Termination. In the event of termination of this Agreement by either Parent or Target, as provided in
Section 10.1, this Agreement shall forthwith become void and there shall be no liability on the part of either Target, Parent, Sub or their respective officers or directors (except as set forth in this Section 10.2). Nothing in this
Section 10.2 shall relieve any party from liability for any breach of this Agreement. 
 10.3 Amendment and Waiver.
This Agreement may be amended, modified or waived only by a written agreement signed by the Parent, Sub, Controlling Shareholder and Sub. With regard to any power, remedy or right provided in this Agreement or otherwise available to any
party, (i) no waiver or extension of time, shall be effective unless expressly contained in a writing signed by the waiving party, (ii) no alteration, modification or impairment shall be implied by reason of any previous waiver, extension
of time, delay or omission in exercise or other indulgence, and (iii) waiver by any party of the time for performance of any act or condition hereunder does not constitute a waiver of the act or condition itself. 
  

 29 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 ARTICLE XI 
 MISCELLANEOUS 
 11.1 Survival of Representations and Warranties. All
representations, warranties, covenants and agreements made by any party in this Agreement or pursuant hereto shall survive the Merger except for the representations, warranties, covenants and agreements contained in Sections 5.3(j), 5.3(o) and 8.2
of this Agreement which shall survive the Merger until the expiration of the applicable statutes of limitations with respect to such matters. All claims made by Parent by virtue of any such representations, warranties, covenants and agreements shall
be made under, and subject to the limitations set forth in, Article IX hereof. 
 11.2 Material Adverse Effect. For
purposes of this Agreement, a “Material Adverse Effect” shall mean a material adverse effect on the financial condition, assets, liabilities (contingent or otherwise), results of operations, business or prospects of the Target, taken as a
whole, or on the Target’s and the Sellers’ ability to consummate the transactions contemplated by this Agreement. For purposes hereof, an adverse effect on the financial condition, assets, liabilities (contingent or otherwise), results of
operations, business or prospects of the Target which has resulted or could reasonably be expected to result in Losses in excess of the amount as set forth in Section 9.3(b) shall be deemed a Material Adverse Effect. 
 11.3 Notices. All notices, demands, or other communications to be given or
delivered under or by reason of the provisions of this Agreement shall be in writing and shall be deemed to have been duly given or delivered when (i) delivered personally, (ii) sent by certified mail, return receipt requested or
(iii) sent via a nationally recognized overnight courier to the recipient for next business day delivery. Such notices, demands and other communications shall be sent to the address indicated below: 
 If to Controlling Shareholder and Target: 
 (*NAME AND ADDRESS CONFIDENTIAL*) 
 With copies to: 
 (*NAME AND ADDRESS CONFIDENTIAL*) 
 If to Parent and Sub: 
 Troy Lowrie 
 Brent Lewis 
 VCG Holding Corp. 
 390 Union Blvd., Suite 540 
 Lakewood, CO 80228 
  

 30 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 With copies to: 
 Mike Ocello 
 1401 Mississippi Avenue #10 
 Sauget, IL 62201 
 Martin A. Grusin 
 780 Ridge Lake Blvd., Suite 202 
 Memphis, TN 38120 
 Facsimile: 901-682-3590 
 or
to such other address as any party may specify by notice given to the other party in accordance with this Section 11.3. The date of giving any such notice shall be (i) the date of hand delivery, (ii) the date sent by telephone
facsimile if a business day or the first business day thereafter or (iii) the business day after delivery to the overnight courier service. Notwithstanding anything contained herein to the contrary, all notices are only effective upon actual
receipt. 
 11.4 Entire Agreement. This Agreement, the Agreement of Merger, and Covenants Not to
Compete constitute the entire agreements between the parties and each such agreement shall be contingent upon execution of the other and the execution of the Ground Lease for the real property located at (*ADDRESS CONFIDENTIAL*) (as shown on
Schedule 11.4(a) hereto) and the execution of the Sales Agreement for the purchase of the building located thereon (as shown on Schedule 11.4(b) hereto). 
 11.5 Non-Waiver. The failure of any party hereto to insist upon performance of terms, covenants or conditions shall not be construed as a subsequent waiver of any such terms, covenants, conditions
unless specifically waived in writing by the parties. 
 11.6 Counterparts. This Agreement may be executed in
counterparts. 
 11.7 Severability. The invalidity of any provision shall not affect the validity
of any other provision contained herein. 
 11.8 Governing Law. This Agreement and the Agreement of Merger shall be
governed by (*STATE CONFIDENTIAL*) law. 
 11.9 Arbitration. Each of the parties hereto agrees to submit to
binding arbitration any and all differences and disputes which may arise between them, their heirs, successors, assigns, employees, officers, directors, affiliates, subsidiaries, or Controlling Shareholder which are related to this Agreement. Prior
to initiating arbitration, the parties shall first meet face-to-face to effect a resolution of the differences. Any differences which the parties are unable to resolve in said face-to-face meeting shall be heard and finally settled at a mutually
agreed upon location by the parties, by binding arbitration in accordance with the Commercial Rules of the American Arbitration Association. If the parties do not agree upon a location, the arbitration proceeding shall be conducted in (*CITY AND
STATE CONFIDENTIAL*). Any award entered in any such arbitration shall be final, binding, and may be entered and enforced in any court of competent jurisdiction. The arbitrator shall make such orders, conduct and schedule all proceedings in
connection with the arbitration so that final arbitration commences no less than thirty (30) days and concludes no later than seventy-five (75) days after a party files the initial notice of arbitration, and so that the final arbitration
award is made and delivered to the parties within ninety (90) days after the filing of the initial notice of arbitration. The cost of such arbitration shall be apportioned as determined by the arbitrator, in any manner determined by him/her
based upon the fault or lack thereof by the respective parties. If the cost of such arbitration is not apportioned by the arbitrator, then the cost shall be borne equally between the parties hereto. Nothing herein contained shall be construed as
preventing any party from instituting legal or equitable action against any of the other parties for temporary or similar provisional relief to the full extent 

  

 31 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 
permitted under the laws applicable to this Agreement, or any such other written agreement between the parties or the performance hereof or thereof or
otherwise pending final settlement of any dispute, difference or question by arbitration. Any such provisional relieve may be modified or amended in any way by the arbitrator at any time after his appointment. 
  

							
	 	 	 /S/(*NAME CONFIDENTIAL*)
	 	 	 	 /S/MO

		 	Initials	 		 	Initials

 11.10 Binding Effect. Benefit. This Agreement inures to
the benefit of the parties hereto and their successors and permitted assigns. 
 11.11 Assignability. This Agreement
shall not be assignable by either party without prior written consent of other party. 
 11.12 Headings. The headings
contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. 
 11.13 Expenses. Each party to this Agreement shall bear all of its own expenses in connection with the execution, delivery and performance of this Agreement and the transactions contemplated hereby,
including without limitation all fees and expenses of its agents, representatives, counsel and accountants. 
 11.14 (*STATE
CONFIDENTIAL*) Business Opportunity Act. The Parties agree that this Agreement has met the conditions (*SECTION CONFIDENTIAL*) of the (*STATE CONFIDENTIAL*) Business and Commerce Code (as amended) (herein “Business Opportunity Act).
The parties agree and stipulate that this sale is exempt from such Business Opportunity Act under (*SECTION CONFIDENTIAL*) in that this Agreement contemplates the sale of stock of an established and ongoing business or enterprise where the sale
represents an isolated transaction involving a bona fide change of ownership or control of such assets. 
 11.15 HSR
Compliance. Promptly following the execution of this Plan, Parent and Sub shall proceed to prepare and file with the appropriate Governmental Entities such requests, reports or notifications as may be required in connection with this
Plan, and shall diligently and expeditiously prosecute, and shall cooperate fully with each other in the prosecution of, such matters. Without limiting the foregoing, Parent and Sub shall (a) file promptly with the Federal Trade Commission and
the Antitrust Division of the Department of Justice the notifications and other information (if any) required to be filed under the Hart-Scott -Rodino Act (“HSR”) with respect to the transactions contemplated hereby and shall use their
commercially reasonable efforts to cause all applicable waiting periods under the HSR Act to expire or be terminated as of the earliest possible date or obtain a Waiver from said agencies (INSERTED THE WORD “AND”, IT WAS INITIALED BY:
(*NAME CONFIDENTIAL*) AND MO) (b) make all necessary filings, and thereafter make any other required submissions with respect to the transactions contemplated hereby under the Securities Act and the rules and regulations thereunder, and any
other applicable federal or state securities laws. 
 11.16 Cooperation. Subject to the terms and conditions of this
Plan, each of the parties hereto will use its commercially reasonable efforts to take, or cause to be taken all action and to do, or cause to be done, all things necessary, proper or advisable under Applicable Laws to consummate and make effective
the transactions contemplated by this Plan. If at any time after 

  

 32 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 
the Effective Date, any further action is necessary to carry out the purposes of this Plan, the parties to this Plan and their duly authorized representative
shall take all such actions. 
 IN WITNESS WHEREOF, the parties have executed this Agreement and Plan of Reorganization on the date first
above written. 
  

			
	VCG HOLDING CORP.:
		
	By:	 	 /S/ MICHEAL L. OCELLO

	Title:	 	PRESIDENT
	
	(*NAME CONFIDENTIAL*):
		
	By:	 	 /S/ MICHEAL L. OCELLO

	Title:	 	V. PRESIDENT
	
	(*NAME CONFIDENTIAL*):
		
	By:	 	 /S/ (*NAME CONFIDENTIAL*)

	Title:	 	PRESIDENT
	
	 /S/ (*NAME CONFIDENTIAL*)

	(*NAME CONFIDENTIAL*)
	
	DATE: 2-9-08

 (*NAME CONFIDENTIAL*) HEREBY JOINS IN THIS AGREEMENT SOLELY FOR THE PURPOSES CONTAINED IN SECTION 4.2
HEREOF. 
  

	
	 /S/ (*NAME CONFIDENTIAL

	(*NAME CONFIDENTIAL*)
	
	DATE: 2-9-08

  

 33 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 TABLE OF CONTENTS 
 EXHIBITS TO 
 AGREEMENT AND PLAN OF REORGANIZATION

 DATED FEBRUARY 9. 2008 
  

			
	 SCHEDULE
	  	 DESCRIPTION

	B	  	AGREEMENT OF MERGER
		
	3.1(b)	  	AVERAGE PRICE
		
	3.3(g)	  	LOCK-UP PROVISION
		
	3.3(h)	  	LEGEND FOR SHARES
		
	4.2(a)	  	COVENANT NOT TO COMPETE ((*NAME CONFIDENTIAL*))
		
	4.2(b)	  	COVENANT NOT TO COMPETE ((*NAME CONFIDENTIAL*))
		
	4.3	  	ESCROW AGREEMENT
		
	4.4	  	OPTION TERMINATION AGREEMENT
		
	5.3(c)	  	SHARE AUTHORIZATION OF TARGET
		
	5.3(f)	  	EXCEPTIONS TO FINANCIAL STATEMENTS
		
	5.3(g)	  	EXCEPTIONS TO LIABILITIES, DEBTS, OBLIGATIONS OR CLAIMS AGAINST TARGET
		
	5.3(h)(i)	  	EXCEPTIONS OF TARGET TO PAYMENT OF ALL TAXES
		
	5.3(h)(vi)	  	EXCEPTIONS OF TARGET RE: STATUTE OF LIMITATIONS FOR ASSESSMENT OF FEDERAL INCOME TAXES OR RETURNS HAVING BEEN EXAMINED BY INTERNAL REVENUE SERVICE FOR ALL PERIODS THROUGH SEPTEMBER 30,
2004

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

			
	5.3(h)(viii)	  	EXCEPTIONS OF TARGET RE: PRESENTLY PENDING FEDERAL, STATE, LOCAL OR FOREIGN AUDITS OR OTHER ADMINISTRATIVE PROCEEDINGS OR COURT PROCEEDINGS WITH REGARD TO ANY TAXES OR
RETURNS
		
	5.3(h)(xii)	  	EXCEPTIONS OF TARGET RE: TAXES OWED AS RESULT OF BEING MEMBER OF AN “AFFILIATED GROUP”
		
	5.3(i)	  	EXCEPTIONS OF TARGET RE: TRANSFERS, ASSIGNMENTS, OR CONVEYANCE OF ASSETS, ADVERSE CHANGES, UNCOLLECTIBLE NOTES OR ACCOUNTS RECEIVABLE, DESTRUCTION, DAMAGE OR LOSS TO PROPERTY, LIENS, CHARGES,
ENCUMBRANCES OR CLAIMS UPON ASSETS, DEFAULTS IN MATERIAL LIABILITIES OR OBLIGATIONS, MATERIAL ADVERSE CHANGES IN TERMS OF CONTRACTS OR INSTRUMENTS, WAIVERS, CANCELATIONS, SALES OR OTHER DISPOSITIONS OF ANY MATERIAL CLAIM OR RIGHT AGAINST OTHERS,
LAPSES RE: PATENTS, TRADEMARKS, TRADEMARK REGISTRATIONS, LOGOS, ASSUMED NAMES, TRADE NAMES, COPYRIGHTS OR COPYRIGHT REGISTRATIONS, OR SUCH APPLICATIONS, LAPSES AS TO ANY LICENSES, PERMITS OR OTHER AUTHORIZATIONS OR TRADE NAMES, TADE SECRETS,
FORMULAS OR PROCESSES, CHANGES IN METHODS OF ACCOUNTING OR ACCOUNTING PRACTICES, DECLARATIONS, PROMISES OR DISTRIBUTIONS OR OTHER PAYMENTS TO CONTROLLING SHAREHOLDER OR ISSUANCE OF ADDITIONAL SHARES, RIGHTS, OPTIONS OR CALLS, OR REDEMPTIONS,
PURCHASES OR OTHERWISE ACQUISITIONS OF SHARES OR CHANGES IN CAPITAL STRUCTURE, INCREASES OR CHANGES IN OBLIGATIONS FOR PAYMENTS OR CONTRIBUTIONS TO EMPLOYEE BENEFIT PLANS OR BONUSES OR INCREASES IN COMPENSATION OR PENSIONS, PAYMENTS, LOANS OR
ADVANCES IN RESPECT OF SOLD, TRANSFERRED OR LEASED PROPERTIES OR ASSETS OR AGREEMENTS, ARRANGEMENTS, OR TRANSACTIONS (EXCEPT FOR COMPENSATION TO OFFICERS AND EMPLOYEES OF TARGET OR CONTROLLING SHAREHOLDER), TRANSACTIONS

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

			
		  	OR EVENTS INCREASING TAX LIABILITIES FOR PRIOR YEARS OF TARGET, LEASES OF REAL PROPERTY OR MATERIAL LEASES OF PERSONAL PROPERTY, OTHER LIABILITIES OR OBLIGATIONS OR TRANSACTIONS OTHER THAN IN
ORDINARY COURSE OF BUSINESS, TERMINATIONS OR AMENDMENTS OR FAILURES TO PERFORM IN ALL MATERIAL RESPECTS OF OBLIGATIONS OR DEFAULTS OF ANY CONTRACT, LEASE, AGREEMENT OR LICENSE, NOTICES FROM SUPPLIERS OR CUSTOMERS CONTEMPLATING STEPS WHICH COULD
MATERIALLY AND ADVERSELY DISRUPT BUSINESS RELATIONSHIPS, AND AGREEMENTS TO TAKE ANY ACTIONS DESCRIBED IN SECTION 5.3
		
	5.3(j)	  	EXCEPTIONS TO MATERIAL CONTRACTS
		
	5.3(k)	  	EXCEPTIONS TO VALIDITY AND BINDING OBLIGATIONS OF MATERIAL CONTRACTS
		
	5.3(m)	  	EXCEPTIONS TO ACCUMULATED FUNDING DEFICIENCIES, MATERIAL LIABILITIES, PLANS OR COMMITMENTS TO CREATE ADDITIONAL PLANS, HEALTH BENEFITS AFTER RETIREMENT, AND COMPLIANCE WITH (*SECTION
CONFIDENTIAL)
		
	5.3(m)(i)	  	LIST OF EACH COMPENSATION ARRANGEMENT OR BENEFIT PLAN
		
	5.3(m)(ii)	  	LIST OF EACH EMPLOYEE PENSION BENEFIT PLAN
		
	5.3(m)(iii)	  	LIST OF EACH EMPLOYEE WELFARE BENEFIT PLAN
		
	5.3(l)	  	EXCEPTIONS OF TARGET AS TO STRIKES, PICKETS, BOYCOTTS, WORK STOPPAGES OR SLOWDOWNS OR OTHER LABOR DISPUTES
		
	5.3(n)	  	EXCEPTIONS AS TO CLAIMS, ACTIONS, SUITS, APPROVALS, INVESTIGATIONS, INFORMAL OBJECTIONS, COMPLAINTS OR PROCEEDINGS PENDING AGAINST TARGET
		
	5.3(o)	  	EXCEPTIONS OF TARGET RE; DISPOSITIONS OF OR PERMITTED LAPSES OR FAILURE TO PRESERVE EXISTING EXCLUSIVE RIGHTS

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

			
	6.1(b)(ix)	  	LIST OF TARGET’S MANAGERS EMPLOYED AT LEAST 60 DAYS PRIOR TO EXECUTION OF AGREEMENT AND PLAN OF REORGANIZATION
		
	6.6	  	THIRD PARTY CONSENTS
		
	11.4(a)	  	GROUND LEASE
		
	11.4(b)	  	SALES AGREEMENT

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 SCHEDULE 3.1(b) 
 The “Average Price” as defined in 3.1(b) shall be: 
 The volume weighted “Average Price” is the ratio of Parent’s
share volume over a 10-day trading period, whereby such ratio for a particular trading day is then applied to the Parent’s closing price reported for such day. This ratio adjusted share price shall be defined as the daily Average Price. The
Average Price is computed using all of the trades that occur on all trading systems that report to and are picked up by NASDAQ at the end of each trading day. The Parent shall rely upon NASDAQ to report reliable and accurate data that includes
volume and closing price information on a daily basis. However, because of the possibility of human and/or mechanical error as well as other factors, the volume and closing price shall be “AS IS REPORTED BY THE NASDAQ” and the Parent
“DOES NOT PROVIDE A WARRANTY OF ANY KIND AND EXPRESSLY DISCLAIMS ALL EXPRESS AND/OR IMPLIED WARRANTIES OF ANY KIND AND MAKES NO REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, TO ANY PERSON OR ENTITY AS TO THE ACCURACY, TIMELINESS,
COMPLETENESS, MERCHANTABILITY, OR FITNESS FOR ANY PARTICULAR PURPOSE. 
 Following is a chart showing the Average Price for each day shown below: 

 

					
	 	 	 10 DAY AVERAGE PRICE
  
	 	 
	Tuesday, January 15, 2008	 	$11.64	 	
	Wednesday, January 16, 2008	 	$11.33	 	
	Thursday, January 17, 2008	 	$11.21	 	
	Friday, January 18, 2008	 	$11.07	 	
	Tuesday, January 22, 2008	 	$10.92	 	
	Wednesday, January 23, 2008	 	$10.77	 	
	Thursday, January 24, 2008	 	$10.65	 	
	Friday, January 25, 2008	 	$10.57	 	
	Monday, January 28, 2008	 	$10.53	 	
	Tuesday, January 29, 2008	 	$10.84	 	
	Wednesday, January 30, 2008	 	$10.95	 	
	Thursday, January 31, 2008	 	$11.09	 	
	Friday, February 01, 2008	 	$11.69	 	
	Monday, February 04, 2008	 	$11.79	 	
	Tuesday, February 05, 2008	 	$11.86	 	
	Wednesday, February 06, 2008	 	$12.06	 	
	Thursday, February 07, 2008	 	$12.21	 	

 For example only, the Average Price used in the Conversion Ratio if the Agreement and Plan of Reorganization
(Agreement) had occurred on February 9, 2008, would be $12.21 (the 10-day volume weighted Average Price for February 7, 2008, one trading day preceding the date of execution of the Agreement). 

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 SCHEDULE 3.3(g) 
 LOCK-UP PROVISION 
 In order to induce Parent to enter into the Agreement and Plan of Reorganization (the “Plan
Agreement”), the New Shareholders agree not to offer, sell or contract to sell, or otherwise dispose of, directly or indirectly (including short sales, sales against the box and/or other hedging or derivative transactions) or announce an
offering of, any shares of Parent Common stock beneficially owned by the New Shareholders for a period of ninety (90) days following the day on which the Plan Agreement is Closed. 
 On the ninety-first (91st) day following the date which the Plan Agreement is Closed and for every month1 thereafter, up to and including the twelfth (12th) month after the Plan Agreement is Closed (collectively referred to hereinafter as “Months Four
Through Twelve”) (in other words, the 4th through the 12th month following the Closing of the Plan Agreement, the Parent agrees that the New Shareholders can sell fifty thousand shares (50,000) of Parent Common stock, subject to the
following conditions: 
 1. The New Shareholders agree not to provide (by lending to) any prospective short-sellers with any of the
50,000 shares of Parent Common stock being authorized to sell under this Lock-Up Provision. 
 2. The New Shareholders shall notify Parent,
within three (3) business days, of any Parent Common stock purchased or sold during the Put Period. 
 3. The New Shareholders further
agree that they will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result, under the Securities Exchange Act of 1934 (the “Exchange Act”), in stabilization or manipulation of the
price of any securities of the Parent to facilitate the sale or resale of the Parent Common stock registered under that certain S-4 Registration Statement set forth in the Plan Agreement and filed with the SEC. 
  

	 1
	 A month shall be defined as each 30-day period after the Closing.

 CONFIDENTIAL TREATMENT REQUESTED 
 Portions of this exhibits indicated by “(*[TEXT]*)” have been omitted pursuant to a request for confidential treatment and such omitted portions have been filed separately with the Securities and Exchange
Commission. 
  

 Schedule 4.4 
 OPTION TERMINATION AGREEMENT 
 No Options.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}]]